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Abstract  
 
Immune thrombocytopenia is a blood disorder, characterised by low platelet 
count, bleeding and bruising. In children, symptoms are generally mild and 
spontaneous remission is common. Literature relating to other paediatric 
conditions is reviewed and considered alongside limited studies with adults 
and children with ITP which suggest that their life is affected by the 
condition. A holistic approach to treatment should be adopted which is 
informed by the psychological profile of ITP.   
The current study used questionnaires completed by children with ITP and 
their parents attending haematology outpatient appointments. 
Questionnaires assessed adjustment variables of emotional and behavioural 
functioning, fatigue, quality of life, and executive functioning. A measure was 
created to explore the effect of subjective appraisal from parents and 
children on the other investigated variables.  
In total, 37 families took part. Results showed most children in the sample 
did not have significant difficulties. However, parents’ ratings of children on 
a measure of total psychological difficulties, and specifically on emotional 
symptoms, were higher for this sample compared with children without ITP. 
Fatigue as rated by parents and children was on average higher for children 
with ITP compared with children without ITP. For a proportion of children 
(20%), ratings on the Global Executive Composite and the Behaviour 
Regulation Index indicated some difficulty with executive functioning, though 
these results should be viewed with caution given the sample size and other 
limitations of the study. Severity ratings of the condition varied between 
parent, child and clinician. Bleeding severity and platelet count generally did 
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not correlate with other measures. Some appraisal measures were 
significantly associated with adjustment variables.  
Possible explanations for the findings are discussed. Results are then 
considered relative to the Risk and Resistance model (Wallander & Varni, 
1992). Despite limitations, this study provides important information that 
contributes to knowledge about the profile of ITP as well as the inter-
relationship between factors that affect well-being in paediatric conditions 
more broadly.  
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1. Introduction  
1.1 Overview  
Chronic physical health conditions can have significant effects on 
individuals’ psychological well being (Barlow & Ellard, 2006; Varni, Limbers, 
& Burwinkle, 2007). The World Health Organisation defines health as a 
multidimensional construct including social and emotional components as 
well as physical aspects (WHO, 1946). In order to provide optimal care as 
healthcare providers, we need to understand the holistic presentation of a 
condition, including both the medical and psychosocial characteristics 
(Department of Health, 2005).  
 
There are some similarities with regard to the psychosocial impact of 
different types of physical health conditions (Stein & Jessop, 1982), such as 
effects of treatments, being perceived as different due to the condition, or 
disruption to a person’s daily routine. However, it has also proved useful to 
study the impact of specific conditions, to determine unique effects. This 
thesis looks at immune thrombocytopenia (ITP), a bleeding disorder, in 
children and the specific issues presented for this condition. The risk and 
resistance model as described by Wallander and Varni (1992) is outlined as 
a model for understanding how psychological, contextual and clinical 
aspects of a condition might interact together, including in ITP.  
 
This thesis explored emotional and behavioural functioning, fatigue, 
executive functioning and quality of life in children affected by ITP. These 
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variables were selected as there is extensive literature to suggest these are 
significant factors affected in children with a range of chronic health 
conditions, as discussed in each section below. Additionally, these aspects 
have been reported or observed by clinicians in paediatric haematology 
clinics for children with ITP, but, as yet, have not been explored in research 
studies. These variables are initially discussed in relation to physical health 
conditions, including those that might be most similar to ITP in children. The 
literature relating to each of these aspects of functioning in adults and 
children with ITP is covered, highlighting gaps in the literature. The potential 
role of cognitive appraisal of the condition, as highlighted in the risk and 
resistance model (Wallander & Varni, 1992), is also discussed. Finally, an 
outline of the current study is given; this study aimed to address omissions 
in previous research and establish the profile of fatigue, executive 
functioning and emotional-behavioural outcomes for children with ITP, as 
well as the inter-relationships between these variables.   
 
1.2 Impact of chronic childhood health conditions 
This chapter outlines evidence to suggest that the presence of a chronic 
health condition is a risk factor for poor outcome in different adjustment 
domains. Children with physical disorders may be at risk of general 
adjustment problems (Barlow & Ellard, 2006), poor psychological well-being 
(Lavigne, & Faier-Routman, 1992) and reduced quality of life (Varni, 
Limbers, & Burwinkle, 2007). Differences in outcomes are seen across 
conditions (Lavigne & Faier-Routman, 1992). Specifically in blood disorders, 
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poorer outcomes have been shown for those with sickle cell anaemia (Anie, 
2005), Von Willibrands disease (Barr et al, 2003), and coagulation disorders 
as a group (Talaulikar, Shadbolt, McDonald, & Pidcock, 2006) compared 
with the general child population.  
 
ITP is another blood disorder that has received recent research interest, 
particularly around understanding the secondary (psychosocial) 
characteristics of the condition.  Investigating ITP would not only tell us 
more about ITP, but also provide information that may help identify aspects 
common to other disorders and isolate those unique to ITP, thus informing 
us more generally about outcomes in chronic conditions and blood 
disorders.  
 
1.3 Immune Thrombocytopenia (ITP)  
Immune thrombocytopenia (ITP) is a rare blood condition, with an estimated 
incidence in children between 1.9 and 6.4 per 100,000 children per year 
(Terrell et al., 2010). The condition is characterised by low blood platelet 
counts, bleeding (e.g., nosebleeds) and bruising. Haemoglobin and white 
cell counts are typically normal (unless as a consequence of significant 
bleeding) (Bannon & Carter, 2007). Diagnosis is based on clinical history, 
physical examination and blood counts but it remains a diagnosis of 
exclusion (Bannon & Carter, 2007); for ITP to be diagnosed, other 
conditions must be considered and ruled out. This includes more serious 
diseases such as leukaemia or congenital blood problems (Bannon & 
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Carter, 2007), and this is likely to cause anxiety for families whilst these 
diagnoses are under consideration.  
 
The terms ‘immune’, or ‘idiopathic’, thrombocytopenia identifies the 
condition as occurring independent of other conditions, and the disease is 
thought to be a dysfunction in the body's immune system, incorrectly 
attacking its own cells (Blanchette & Bolton-Maggs, 2010). The condition 
affects equal numbers of boys and girls, although at younger ages there are 
slightly more boys with the condition (Kühne et al., 2001). In children, 
symptoms are often mild, although there is a very small risk of internal 
bleeding and, in particular, intracranial haemorrhages which can be life-
threatening (Blanchette & Bolton-Maggs, 2010). ITP should not impact on a 
child’s ability to engage with most age-expected activities, although they 
may be advised, particularly in the initial stages of an illness, to avoid 
activities which are at high risk for head injury or internal trauma (Bannon & 
Carter, 2007). 
 
In children with ITP, spontaneous remission is common (Neunert et al., 
2013). Chronic ITP in children is defined as lasting longer than 12 months 
and occurs for 15-20% of children with ITP (Bannon & Carter, 2007). 
Treatment options include, among others, intravenous immunoglobulin, 
splenectomy and steroids (Blanchette & Bolton-Maggs, 2010). Decision to 
treat ITP is largely based on clinical factors, such as bleeding severity. 
However, due to good spontaneous remission rate in children and the risks 
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associated with treatments, a ‘watch-and-wait’ approach is usually adopted 
(Blanchette & Bolton-Maggs, 2010), meaning that active treatment is 
withheld unless clinical risk reaches a certain level. Blood tests are carried 
out routinely to monitor the condition. However, in line with the World Health 
Organisation’s holistic definition of health (WHO, 1946), clinicians also need 
to consider all aspects of a child’s presentation, and adopt a 
biopsychosocial assessment of a child’s needs. It has been suggested that 
a range of factors, including bleeding symptoms and quality of life should be 
considered in treatment decisions for ITP (Buchanan & Adix, 2001).  
 
As a chronic condition, ITP may have features common to other health 
conditions. At present, the psychosocial components of ITP are 
understudied, so this thesis draws on literature for other physical health 
conditions, including other non-malignant blood disorders, such as sickle 
cell anaemia and haemophilia. These make a good comparison to ITP as 
they also require regular blood tests and hospital appointments and involve 
a degree of uncertainty about the course of the illness. However, treatment 
of ITP is more conservative than these two comparison conditions and on 
the whole it is usually considered to be less severe (Bannon & Carter, 
2007). Furthermore, it may be hypothesised that there are unique features 
of ITP that contribute to variability in adjustment, including the visibility of the 
condition through bruising and bleeding, the particular uncertainty 
associated with the ‘watch-and-wait’ treatment approach, potential emotions 
such as anxiety or even guilt due to its unknown cause/aetiology, the 
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confusion of multiple treatment options and the approach to restricting 
physical activity. Research into the well-being and quality of life for children 
with ITP has begun but other more specific areas of psychosocial 
functioning have not been investigated. 
 
1.4 Risk and Resistance Model 
Although having a chronic health condition may be a risk factor for poor 
outcomes, researchers have suggested that it may be that an interplay of a 
range of factors determines outcome, and this may explain why only certain 
individuals experience difficulties. Wallander and Varni (1992) developed 
the risk and resistance model, also known as the disability-stress model, for 
understanding the impact of disability and illness (Figure 1). Although not 
tested in this study, the model is described here in order to provide a 
theoretical framework for understanding the findings of the study.  
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Figure 1: Risk and Resistance Model (taken from Wallander & Varni, 1992)  
 
 
The model was developed from a background of literature that showed that 
there is wide individual variation in adjustment to a chronic health condition, 
which cannot be accounted for by presence of the condition alone 
(Wallander & Varni, 1992). For instance, Wallander, Varni, Babani, Banis, 
and Wilcox (1988) found significant variation in maternal reports of 
externalising behaviour problems and social competence, as measured on 
the Child Behaviour Checklist (Achenbach & Edelbrock, 1983), for children 
Condition factors 
 
Psychosocial 
stress Adjustment/adaptation 
Stress processing 
Personal 
factors 
Functional ability/ 
independence  
 
Social-ecological 
factors 
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with chronic health conditions, suggesting that other factors must have an 
impact on outcomes. Analysis showed that variation occurred dependent on 
condition, gender and situational variables, such as family income. Similarly, 
in a population-based survey of 17,110 families (Adams & Hardy, 1989), 
whilst 31% of children were reported to have chronic physical health 
conditions, only a small proportion of these experienced problems or 
significant impact on their lives (Newacheck & Taylor, 1992). In this study, 
there was significant heterogeneity in the type of conditions surveyed, 
including allergies. The impact on children and young people may be 
different for more severe and enduring conditions, or those requiring 
hospital treatments.  
 
The model shown in Figure 1 proposes that there are risk and resistance 
factors that contribute to outcome and adjustment. The authors proposed 
that risk factors are those elements that contribute to a poor outcome; 
resistance factors provide some protection against poor outcome (Wallander 
& Varni, 1992).  Due to the complexity of the model, often only sections of 
the model and selected pathways have been tested in any given study. 
Although a brief description of some of the key findings are discussed below 
in order to illustrate the relevance of this model to this particular research 
study, a review of full the evidence base for the model is beyond the scope 
of this thesis.  
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Risk factors include illness parameters, such as overall condition severity, 
specific symptoms and the illness’s visibility, functional (in)dependence, and 
ongoing daily stress, which may or may not be associated with the illness 
itself. There are mixed results on the link between the severity of the illness 
and outcome (Billings, Moos, Miller, & Gottlieb, 1987; Casey, Brown & 
Bakeman, 2000). To explain this, the model suggests that specific disease 
factors may have both direct and indirect effects on outcome. For instance, 
severity has been shown to be associated with stress (Casey et al., 2000) 
and both stress related to the illness (Casey et al., 2000, LeBovidge, 
Lavigne & Miller, 2005) and general life stresses (Coker et al., 2011) have 
been found to affect psychological adjustment outcome for children. 
Similarly, pain (as a condition risk factor) has been shown to be directly 
related to a child’s adjustment, for instance mood outcome (Gil et al., 2003). 
However, pain may also limit the amount of activity that a child can engage 
with, indicating an indirect route for symptoms of a condition to impact on 
outcome (Gil et al., 2003). Functional independence is suggested in the 
model to mediate the relationship between condition variables and outcome, 
and poorer emotional outcome is indeed observed in paediatric populations 
with cancer with worse functional ability (Varni, Katz, Quiggins, & Friedman-
Bender, 1996, as cited by Wallander & Varni, 1998).  
 
‘Resistance factors’, including intrapersonal, socio-ecological and stress 
processing generally attenuate the effect of risk factor variables in both a 
direct and indirect way, and therefore lead to better outcome (Wallander & 
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Varni, 1998). Stress processing encompasses cognitive appraisal and was 
influenced by the work of Lazarus and Folkman (1984), who suggest that it 
is the perception of an event or situation that influences outcome rather than 
the nature of the event itself. In support of this, Varni and Setoguchi (1996) 
found no association between objective measures of limb loss and 
perceived physical appearance but more positive perceived physical 
appearance was related to lower depressive symptoms. Walker and 
colleagues (Walker, Smith, Garber, & Claar, 2007) found that in children 
with chronic abdominal pain, appraisal of daily stressors was significantly 
associated with adjustment, as measured by depressive ratings and somatic 
symptoms. Illness appraisal is discussed further later in the chapter. The 
model suggests that a person’s ability and style in processing stress is 
influenced by personal attributes (including age, gender, and personality 
factors), a finding which has been verified in numerous studies (e.g., Mak, 
Blewitt, & Heaven, 2004). Other sociological and contextual factors such as 
social economic factors and family background (Drotar, 1997; Karlson et al., 
2012; Wagner et al., 2003) have been shown to influence outcome, directly 
and through their effects on appraisal. However, discussion of these factors 
is beyond the scope of this thesis. For further evidence and discussion see 
Wallander and Varni (1998). 
 
Though the authors did not originally specify what ‘adjustment outcome’ 
referred to, research has since used behavioural, emotional and quality of 
life measures as discussed below. As each area of adjustment is explored, 
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the literature on the impact of personal factors (age and gender) and 
condition factors will be briefly discussed where literature is available. For 
ITP, the main illness factors discussed are bleeding severity and platelet 
count and these are discussed in relation to the different outcome variables 
where research exists.  
 
The risk and resistance model (Wallander & Varni, 1992) does have 
limitations and in particular it has been criticised for incorrectly specifying 
moderating and mediating variables (Holmbeck, 1997). Also, the model 
describes a clear separation between risk and resistance factors, but it has 
been suggested that many factors could function as both, for example 
where high values of a factor (e.g., use of active coping methods) could 
result in positive outcome but low scores result in negative outcome 
(Olsson, 2008). Nevertheless, Wallander and Varni (1992) emphasised that 
mapping out variables that affect outcome would help develop intervention 
and prevention programs to support individuals and families to manage and 
adjust to chronic conditions. 
 
Due to the complexity of the model and the design and scope of this study, 
the model was not explored and tested in relation to ITP. Rather, the 
primary aim of this study was to explore a range of adjustment outcomes, 
not previously investigated for ITP and the model provided a framework to 
consider how these outcomes may interact with each other and contribute to 
variation in outcome. This study aimed to include a wider exploration of 
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adjustment outcomes in ITP, whereas previously research has focused on 
clinical outcome and more recently quality of life only. After various 
adjustment outcomes have been discussed, the role of cognitive appraisal in 
relation to ITP is covered and then a suggested risk and resistance model 
for ITP is presented.  
 
 
1.5 Psychological adjustment  
1.5.1 Behavioural problems  
Behavioural problems have been used as a measure of adjustment in the 
risk and resistance model for chronic illnesses (Wallander & Varni, 1998). 
When referring to behaviour problems, this thesis is referring to externally 
observable behaviours by the child or young person that have a negative 
effect on the environment around them (Eisenberg et al., 2001). Scales to 
assess behaviour or conduct problems have items that cover hitting out or 
fighting with others, destroying things, and disobedient behaviour (e.g., 
Achenbach & Edelbrock, 1983; Goodman, 1997). As some scales also 
include tantrums, there may be some overlap with emotional difficulties and 
the display of these. The discussion of the literature below does not include 
observable problematic habitual behaviours such as nail biting or bed-
wetting.  
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 Behavioural problems: general health conditions. 
Chronic health conditions have been shown to be associated with 
behavioural problems, for instance as measured by the externalising 
subscale of the Child Behaviour Checklist (Achenbach & Edelbrock, 1983; 
Pinquart & Shen, 2011) and using bespoke measures 
(Gortmaker, Walker, Weitzman, & Sobol, 1990). Pinquart and Shen’s meta-
analysis (2011) compared data across many different studies. The analysis 
included 569 studies involving 51,422 child participants, with 1,897 children 
with sickle cell disease. As the researchers did not limit the analysis to 
studies published in English, this meta-analysis also provides cross-cultural 
data. They found increased levels of externalising behaviours overall, a 
finding that was observed in the studies of children with sickle cell. Across 
conditions, increased behaviour problems were particularly reported by 
parent compared to child ratings, with adolescent ratings having the 
smallest effect size. A significant effect for gender was found, with higher 
reported externalising problems in studies with a majority of males in the 
sample. This finding does parallel similar patterns found in normal 
populations (Leadbeater, Kuperminc, Blatt, & Hertzog, 1999). In the meta-
analysis, studies were only included if they had used the Child Behaviour 
Checklist (Achenbach & Edelbrock, 1983). However, this scale has been 
criticised for use with physical conditions due to the overlap between the 
somatic complaints subscale and characteristics of the illness itself (Perrin, 
Stein, & Drotar, 1991).  
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The only blood disorder in the meta-analysis above was sickle cell disease. 
There is some evidence of behaviour problems in haemophilia (Evans, 
Cottrell & Shiach, 2000), although most studies show behavioural 
functioning within the normal range (Trzepacz, Vannatta, Davies, Stehbens 
& Noll, 2003). However, even in conditions identified as ‘benign’, 
behavioural problems have been reported. For instance, in studies of benign 
epilepsy, parents rated their children as having significantly higher rates of 
behavioural problems compared with norms (Connolly et al., 2006) or 
matched controls (Weglage, Demsky, Pietsch, & Kurlemann, 1997). Most 
children will outgrow this form of epilepsy in childhood (Peters, Camfield, & 
Camfield, 2001) and in this way it is similar to the pattern of recovery found 
in childhood ITP.  
 
Behavioural issues in ITP.  
Exploration of behavioural issues in ITP is extremely limited. However, we 
might expect a similar behavioural adjustment profile in ITP to other physical 
health conditions. Although ITP may be considered less severe than sickle 
cell disease (Bannon & Carter, 2007) discussed above, parents do report 
problem behaviours in some other benign conditions (Connolly et al., 2006).  
 
In studies involving adults with ITP, patients reported problems with mood 
swings and anger (Mathias et al., 2008), largely related to steroid treatment. 
In the study, the extent to which these problems were externalised was not 
explored, nor were any potential effects of gender. For children and young 
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people, anger and mood changes may present as conduct or behavioural 
problems, but as yet this has not been investigated for those with ITP. 
Anecdotal reports from clinicians indicate that families report problems with 
behaviour in children with ITP (K. Sibson, personal communication, 
February 4, 2014), beyond those who may be experiencing effects from 
steroid treatments (Suarez, Rademaker, Hasson, & Mangogna, 1986) and 
that these may have a significant impact on a child’s well-being, participation 
in daily life, social contact, academic functioning. Research needs to 
examine the prevalence of these problems, compared with normative 
scores, and the extent to which this may be associated with other 
psychosocial characteristics of the condition. In particular, emotional 
difficulties and problems with conduct are often observed together in 
children with chronic health conditions (Pinquart & Shen, 2011). 
 
1.5.2 Mood and emotional symptoms 
Mood or emotional symptoms have also frequently been used as a measure 
of adjustment for children with health conditions. ‘Emotional symptoms’ or 
‘emotional functioning’ as discussed here encompasses low 
mood/depression and anxiety as measures often combine these factors. 
Where attempts have been made to measure depression and anxiety 
separately, this is made clear. (Emotional functioning as described here 
does not refer to the ability of children and young people to recognise and 
appropriately respond to emotions.)  
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Mood and emotional symptoms: general health conditions. 
Using large samples from several studies, Varni, Limbers and Burwinkle 
(2007) found that self-reported ‘emotional functioning’ was significantly 
lower for children with chronic health conditions than a healthy control 
group. However, emotional functioning was based on a brief subscale of a 
wider quality of life measure, which may bring into question the construct 
validity of this measure. In a different meta-analysis in which studies did use 
specific measures of emotional functioning and depression, depressive 
symptoms were worse in children with chronic physical conditions (Pinquart 
& Shen, 2011), although there was large variation across conditions, 
emphasising the importance of measuring the impact on emotional 
wellbeing for individual conditions. Most relevant to the current study, other 
blood disorders such as sickle cell are associated with depressive 
symptoms in children (Yang, Cepeda, Price, Shah, & Mankad, 1994).  
 
It is important to note that particular treatments such as steroids can have 
an impact on mood (Stuart, Segal, & Keady, 2005). Also, in one study 
(Mrakotsky et al., 2013) exploring psychological symptoms in children with 
inflammatory bowel conditions, sleep mediated the effect of steroids on 
depressive scores so treatment effects may also be influenced by other 
factors. Furthermore, how an illness is perceived has been shown to have 
an effect on mood. That is, a more positive appraisal is correlated with 
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better emotional outcome (Lewis & Kliewer, 1996). This will be discussed 
further in the section below on illness appraisal. 
 
 Mood and emotional symptoms: ITP. 
Through focus groups consisting of 15 adults in total, 93% of people with 
ITP (14 adults) expressed issues related to emotional health (Mathias et al., 
2008), including depressive symptoms such as low mood and loneliness, 
anxiety around consequences of the illness, and mood swings. This 
categorisation was broad and these are descriptive results since the study 
did not include a quantitative measure of emotional difficulties. In children 
with ITP, parents have reported emotional changes, specifically emotional 
lability, and further research in this area has been recommended 
(Freedman, Garvey, Elinder, & Blanchette, 1998). A possible biological 
mechanism for mood changes in ITP could be explained by the reduced 
level of platelets and their role in the transport and re-uptake of serotonin, a 
neurotransmitter involved in mood regulation (Berger, Gray & Roth, 2009). 
In a similar way to other paediatric conditions, and as described in the risk 
and resistance model (Wallander & Varni, 1992), cognitive appraisal and 
general understanding of ITP may impact on the emotions of this group but 
this has not been explored. Indeed, some authors have suggested that 
uncertainty around illness may exacerbate feelings of anxiety or distress 
(Hoff, Mullins, Chaney, Hartman, & Domek, 2002; Ingerski et. al., 2010). It 
has been suggested that there needs to be investigation into how mood 
disorders may interact with other characteristics, such as fatigue in children 
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with ITP (Newton et al. 2011; Zehnder et al., 2010), particularly as these 
factors have been hypothesised to effect each other for other chronic 
conditions (Hewlett et al., 2011). To date, there has been no study that has 
used standardised measures of mood or emotion for children with ITP.  
 
1.5.3 Fatigue  
Definition and measurement issues.  
Fatigue is recognised as a subjective experience of tiredness and/or 
decreased energy, expressing itself in physical, social or emotional 
domains, which is persistent over time and distinctly abnormal (McCabe, 
2009). Fatigue may be present in individuals with low mood, but mood and 
fatigue may also exert independent effects (Visser & Smets, 1998). 
Measures of fatigue, particularly in child populations, both with and without 
chronic physical health conditions, have been slow to develop and research 
of fatigue in children remains scarce (McCabe, 2009). Furthermore, studies 
that have examined fatigue in paediatric settings have often used proxy 
reports from parents or clinicians, which have shown a large discrepancy 
with child reports (Hinds et al., 1999). As fatigue is largely considered a 
subjective measure, it is vital to gain self-report in this domain. Varni and 
colleagues (Varni, Burwinkle, Katz, Meeske, & Dickinson, 2002) have 
produced a measure that assesses fatigue in children as young as 5 years 
old, with adapted wording and use of smiley faces for responding. It is 
important to consider a wide range of ages as population surveys indicate 
that there may be differences in experience of fatigue between adolescents 
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and younger children (Jordan et al., 2000). It is important to establish the 
degree of fatigue in any condition as it may affect a child’s functioning on 
several domains, such as cognitive functioning and school performance and 
ability to self-regulate, possibly having an impact on emotional functioning  
(Swain, 2000) as discussed above.  
 
Fatigue: general health conditions. 
Children report high levels of fatigue in a range of conditions, including 
cancer (Hicks, Bartholomew, Ward-Smith, & Hutto, 2003), multiple sclerosis 
(MacAllister et al., 2009), and sickle cell anaemia (Panepinto et al., 2014). 
Fatigue might be anticipated in conditions that affect bodily functioning in a 
severe way or conditions that require substantial chemotherapies, known to 
alter fatigue levels. However, it has been identified in other conditions. For 
instance, in systemic lupus erythematosus, an auto-immune disease with 
symptoms affecting the blood and skin, 67% of children identified problems 
with fatigue (Houghton, Tucker, Potts & Mckenzie, 2008). However it should 
be noted that this study used a relatively small sample size (n=15), and 
used a fatigue measure that has not been validated for children. This also 
meant that normative comparisons were not possible. Across a range of 
chronic conditions, the experience of fatigue is identified by children as an 
important symptom (Eddy & Cruz, 2007) and may affect general attitude 
toward illness (Iobst, Nabors, Brunner, & Precht, 2007). Fatigue has been 
associated with academic performance and mood, and could be a result of 
the condition itself, or of the treatment (McCabe, 2009).  
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Although in the general population there is a trend for girls to report more 
fatigue and be at risk for persistent severe fatigue (Viner et al., 2008), 
studies of fatigue in chronic conditions have not always explored gender 
differences. Using both parent and child reports may help to distinguish 
whether this is a gendered report bias or a difference in the presentation of 
fatigue for girls and boys. Also, many studies in chronic conditions have not 
asked younger age groups, despite measures being available.  
 
Fatigue: ITP. 
Mechanisms for fatigue in ITP are poorly understood (Zehnder et al., 2010) 
but possible contributors to fatigue may be restrictions in physical activity, 
worry and stress (Hill & Newland, 2015), insomnia related to corticosteroid 
treatment (Stuart et al., 2005) and, for a very small proportion of ITP 
patients, anaemia caused by excessive bleeding (Liebman & Pullarkat, 
2011).  
 
Through a literature review of 39 articles of adults with ITP and adult focus 
groups, Mathias et al. (2008) found various reports of fatigue. The focus 
groups were facilitated by a trained moderator using a semi-structured 
interview format, and two researchers analysed each transcript. Fatigue was 
mentioned by 14 out of 15 people (93%) in two focus groups, but not 
mentioned at all in a third group. One potential limitation of this study is that 
it was unclear if the researchers that conducted the literature search were 
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the same as analysed the transcripts, which may influence how themes 
were extracted.  
 
In other adult ITP studies, using a generic quality of life measure, scores on 
an energy/vitality subscale have shown both significant (McMillan, Bussel, 
George, Lalla, & Nichol, 2008) and non-significant differences when 
compared with normal populations (Zhou et al., 2007). Of note, in the latter 
study, energy was significantly lower in adults with ITP of duration at least 
six months, compared with those with more acute ITP. This could indicate a 
cumulative effect of fatigue over time. In another study, 39% of UK adult 
respondents with ITP had significantly higher frequencies of fatigue and this 
was associated with reduced platelet count (Newton et al., 2011). The 
majority of participants in this study had chronic ITP; it is unclear whether 
this association between platelet count and fatigue would be observed in the 
acute stages. No measures of emotional functioning were used so it is 
unclear whether the concurrent effects of symptoms of depression were 
affecting fatigue levels. Indeed, the researchers recommend that these 
measures be used in future studies. It should also be noted that the results 
were obtained through questionnaires sent through ITP support 
associations, with a response rate of 31% (585 adults). Members of the 
associations and those that responded may not represent the whole ITP 
population. Whilst a greater percentage of women reported fatigue than men 
(41% of women versus 33% of men) this difference was not a statistically 
significant effect. Some researchers have suggested that different 
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physiological mechanisms, namely oxidative stress, may be different for 
men and women with ITP and this may have an impact on fatigue 
experiences (Kamhieh-Milz & Salama, 2014).  
 
In children with ITP, there are descriptions of fatigue in the literature, 
confirmed in interviews with children, parents and clinicians (Barnard et al., 
2003). A postal survey conducted through the UK-based ITP Support 
Association (Sarpatwari et al., 2010), found reports of fatigue in children, 
which 6-10% of children identified as contributing to them missing school.  It 
should be noted that the 94 children that responded may have been a self-
selecting group (that is, only those with the worst symptoms of ITP and 
fatigue may have responded). If participants were captured attending routine 
clinic appointments, some of this self-selection bias may be reduced. 
Reports of fatigue in children with ITP have also been found through review 
of clinical notes (Blatt, Weston, & Gold, 2010). In this instance, authors 
searched for reports of the symptoms in the notes and did not do any 
comparison with a different group of patients without ITP, making it difficult 
to establish the extent to which fatigue may be different for this group, 
compared with the normal population and other paediatric conditions. Apart 
from these accounts, no systematic investigation of fatigue has been 
conducted in children with ITP, including investigation of the link between 
fatigue and platelet count, similar to that conducted by Newton et al. (2011) 
for adults, or exploring gender differences or treatment effects. This lack of 
research is in line with a general dearth of literature for fatigue in children 
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(McCabe, 2009). As many children with ITP will not be receiving active 
treatment, it may be more possible to attribute fatigue to the condition itself.  
 
1.5.4 Executive functioning deficits 
Executive functioning is a set of abilities concerned with planning, initiation, 
organisation, self-monitoring and regulation (Elliott, 2003). Executive 
functioning may be associated with the three variables mentioned above 
(behaviour, mood and fatigue), or may mediate or moderate the impact of 
ITP on these variables.  
 
Frustrations in struggling to think and process things may manifest in 
behavioural problems. In epilepsy, three years following onset of first 
seizure, executive function difficulties were a significant predictor for poorer 
behavioural outcomes (Baum et al., 2010). Also in a paediatric cancer 
group, executive functions, including working memory, cognitive flexibility, 
self-monitoring and behavioural inhibition, were all significantly correlated 
with behaviour problems (Campbell et al., 2009). 
 
In adults it is established that mood disorders have an impact on executive 
functioning (Fleming, Blasey, & Schatzberg, 2004). There is limited 
investigation into the relationship between mood and executive functioning 
in children. On tests of executive functioning and problem solving, anxious-
depressed boys (aged 9-11 years and with an absence of any physical 
illness) scored worse compared with controls from the same class 
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(Emerson, Mollete & Harrison, 2005). Conversely, lower executive 
functioning may influence mood through the effect on ability to cope with 
every day stresses, in stress perception and stress processing ability 
(Williams, Suchy, & Rau, 2009). However, in one study, in children with 
ADHD, cognitive inattentive symptoms explained less than 1% of variance in 
emotional lability (Sobanski et al., 2010).  
 
One study of children with multiple sclerosis (MS), found that executive 
function, as measured by two neuropsychological tests, was significantly 
associated with cognitive fatigue (Goretti et al., 2012), although parent and 
child reports were associated with different tests. Unfortunately, this study 
does not describe when the reports of fatigue were requested. If these were 
given straight after a poorly performed test, this may have affected the 
ratings, with participants trying to justify or explain their performance through 
fatigue. This study compared scores to matched controls but there was little 
evidence to suggest that they had been matched on characteristics that 
would affect fatigue levels, apart from presence of significant illness or 
injury.  
 
The link between fatigue and executive function is further supported by 
findings in patients with chronic fatigue, where switching attention and 
divided attention have both been found to be significantly different from the 
normative mean (Haig-Ferguson, Tucker, Eaton, Hunt, & Crawley, 2009). 
However, in MS and chronic fatigue syndrome, fatigue is likely to be 
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severely affected; it is unclear whether lower levels of fatigue may still have 
an impact on executive functioning. It is important to investigate executive 
function for its potential effect on other variables (behaviour, mood and 
fatigue) but it may also have other effects on a child's well-being and quality 
of life. 
 
 Executive function in general health conditions 
In adults, there are several studies that document executive function deficits 
in particular physical illnesses (Schillerstrom, Horton, & Royall, 2005). In one 
study, 72% of adult (medical) inpatients performed poorly on bedside 
executive function tests (Schillerstrom, Deuter, Wyatt, Stern, & Royall, 
2003). However, the situation of being in hospital may have an effect on 
executive functioning, independent of physical state. Although research is 
limited, several findings of executive function deficits have been reported for 
children with various blood disorders. Problems with inattention have been 
found in children with haemophilia through informant reports (Spencer, 
Wodrich, Schultz, Wagner, & Recht, 2009) and neuropsychological testing 
(Whitt et al., 1993). A particular strength of this latter study was that 
practitioners carrying out the testing were blind to the study objectives. In a 
meta-analysis review of neurocognitive profiles of children with sickle cell 
disease, 11 out of 13 studies found difficulties in executive functioning 
(Berkelhammer et al., 2007). Although impairments may be larger in those 
with infarcts (occlusion or haemorrhage in the brain), one study found that 
13% of children without any evidence of silent infarct, which may be a closer 
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comparison to children with ITP, had deficits in executive function compared 
with 0% of healthy siblings (Schatz, Brown, Pascual, Hsu, & DeBaun, 2001). 
More recently, a study using neuropsychological tests found poorer 
performance on a test of planning and execution in children with sickle cell 
compared with healthy controls, matched for socioeconomic status 
(Hijmans, Fijnvandraat, et al., 2011). In this study, 79% had no history of 
stroke or observable vascular blockage, although silent infarcts were not 
examined. Beyond vascular injury (infarct), executive function may be 
affected by more general changes in blood flow and pressure, as deficits in 
executive function are present in children with hypertension, as reported by 
parents (Lande et al., 2009).  
 
There is some evidence for steroid effects on executive function. For 
example, for younger child patients with cancer, during steroid treatment 
weeks, emotional control and behaviour regulation sub-scales of the 
Behaviour Rating Inventory of Executive Function, BRIEF (Gioia, Isquith, 
Guy & Kenworthy, 2000a) were significantly worse than off-steroid weeks 
(Mrakotsky et al., 2011). Similarly in inflammatory bowel disease, for 
children (aged 8-17 years) on steroid treatment, reports from children 
themselves and parents indicated problems with executive function, 
although these effects were modest and the effect of steroids on self-
reported metacognition was not significant after controlling for disease 
severity (Mrakotsky et al., 2013). However, there is some evidence for 
39 
steroid effects on executive function so this should be considered in any 
study.  
 
To date, exploration of executive function in chronic conditions has been 
limited. Many studies have used neuropsychological tests, which have been 
criticised for lower ecological validity (Anderson, 2002), as they are often 
conducted in settings that are quiet and controlled, and also increase the 
demand for child participants in research. As well as eliminating these 
disadvantages to neuropsychological testing, self and informant reports can 
draw on daily observation and experience over several weeks to give 
advantage over a single point in time investigation (Payne, Hyman, Shores, 
& North, 2011) 
 
Executive function in ITP. 
Generalised cognitive difficulties have been reported by adults with ITP 
(Frith, Watson, Maggs, & Newton, 2012) using a self-report measure 
(Cognitive Failures Questionnaire; Broadbent, Cooper, FitzGerald, & 
Parkes, 1982).  Self-report could both overestimate cognitive difficulties, if 
the individual perceives the problem to be worse, or underestimate if 
individuals fail to remember how many errors they have made. The study 
found that cognitive problems were unrelated to platelet count and steroid 
use but were significantly related to fatigue.  
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Cognitive problems have been reported in children with ITP (Matoth, Zaizov, 
& Frankel, 1971) and reported anecdotally from haematology clinics (K. 
Sibson, personal communication, February 4, 2014) but have not been 
studied in detail or more rigorously. A recent review of the management for 
ITP calls for further research into the cognitive profile of patients with ITP 
(Cooper, 2014). Given the limitations in self-report and neuropsychological 
testing, reports from other sources may be useful to establish the extent of 
cognitive problems and reports from family members of children may be 
relevant and, as yet, have not been included in research.  
 
Executive function, as a specific domain of cognition, has not been 
investigated in children or adults with ITP. Although intracranial 
haemorrhage in ITP is rare, it is possible that micro-bleeds that go 
undetected may be having an effect on cognitive function. Similar to other 
haematological conditions, executive function may still be affected in 
children with ITP, regardless of bleeding in the brain (Bannon & Carter, 
2007). In addition, increased anxiety or low mood may have an impact on 
executive functions, as may activity levels (Diamond & Lee, 2011), or steroid 
use. Therefore there are several reasons why it is important to investigate 
the profile of executive functioning in children with ITP and the inter-
relationships between executive function, mood and fatigue.  
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1.5.5 Quality of Life  
Quality of life (QoL) can be defined as a subjective assessment of the extent 
to which personal goals, standards and values have been met, and the 
achievement of a desirable life (Diener, 2006; World Health Organisation, 
[WHO], 1997). It is affected by a person’s status, their relationships, and 
their environment (WHO, 1997). In the literature about chronic health 
conditions, the term health-related quality of life (HRQoL) has been used to 
focus on specific health-related elements affected by the condition. In recent 
years, there has been a growing emphasis on assessing quality of life in 
relation to a children’s physical health (Varni, Limbers, & Burwinkle, 2007).  
 
 Quality of Life: Impact of chronic physical health conditions. 
Many studies have shown that having a chronic condition affects a child’s 
quality of life (Ingerski et al., 2010; Varni et al., 2007). In one study of a 
range of different physical conditions, treatment, course of the illness 
(persistent or intermittent), length of diagnosis and severity all affected 
parent and child reports of child overall quality of life (Varni et al., 2007). 
However, this study did not include any haematological disorders, and the 
sample sizes meant that participants could not be demographically matched 
across conditions. In contrast, Miners et al. (1999) did not find any 
correlation between disease characteristics (specifically, bleeding 
frequency), and quality of life for those with haemophilia. In another review 
across seven different chronic conditions, including sickle cell disease, 
children’s quality of life as reported by themselves and their parents, was 
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significantly worse than a healthy control group (Ingerski et al., 2010). This 
study found differences between conditions, which supports the importance 
of considering individual chronic illnesses as they may present unique and 
differential effects. This study controlled for demographic variables, which 
were significantly different across conditions, although it failed to control for 
other disease characteristics such as severity and length of diagnosis. 
Parent reports also indicate lower quality of life in children even for 
conditions identified as medically benign (Connolly et al., 2006).  
 
The factors discussed above have been linked with quality of life for other 
health conditions. For instance, it has been shown that for children with 
epilepsy, mood and quality of life are related (Tracy, Dechant, Sperling, 
Cho, & Glosser, 2007) and that anxiety and depression may moderate the 
relationship between disease characteristics and quality of life in children 
with multiple sclerosis (MS) (Janssens et al., 2003). Significant correlations 
on formal measures have also been found between fatigue and quality of life 
in a sample of children with MS (MacAllister et al., 2009). A 2006 study 
(Connolly et al., 2006) found a significant correlation between lower 
cognitive function and reduced quality of life in epilepsy. The conceptual and 
methodological overlap of these concepts was considered throughout this 
current study.  
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Quality of life: Impact of ITP. 
In a sample of 236 people over 14 years old with ITP, health related quality 
of life assessed using a generic quality of life measure was significantly 
lower on all domains compared with the normal population in China (Zhou et 
al., 2007). In this study, using a bespoke visual analogue measure, fear of 
bleeding was a significant predictor of reduced HRQoL. Reduced HRQoL in 
adults with ITP has also been found in an American study (McMillan et al., 
2008). 
 
ITP may affect a child’s life in several ways. Some of these may be similar to 
other chronic conditions and include the disrupted routine and stress caused 
by hospital visits, the invasiveness and pain caused by medical procedures, 
the uncertainty around illness and the psychological impact of feeling 
different. More uniquely to ITP, it is possible that characteristics such as 
possible restrictions on physical activity, visible presentations of the illness 
(bleeding and bruising) and the ‘watch-and-wait’ treatment approach 
recommended in childhood ITP could be anticipated to affect a child’s 
overall quality of life. For instance, in a questionnaire survey, children with 
ITP reported being bothered about the restrictions in their physical activities, 
and this was more so than for adults with the condition (Sarpatwari et al., 
2010).  
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Klaassen et al. (2013) found that quality of life measured using the Pediatric 
Quality of Life InventoryTM (Varni et al., 2002) was significantly lower in 
children with ITP, compared with values for a healthy population. In recent 
studies, it has been shown that quality of life, as measured with the Kids ITP 
tools (Klaassen et al., 2007), an ITP specific quality of life measure, is likely 
to differ between acute/newly diagnosed and chronic child ITP patients 
(Mokhtar, Farid, Shaker, & Farrag, 2014), and across the first six months of 
diagnosis (Heitink-Pollé et al., 2014; Strullu et al., 2013). The relationships 
between fatigue, executive functioning, emotional and behavioural 
functioning and quality of life have not been looked at for adults or children 
with ITP.  
 
1.6 The role for illness appraisal 
It has been discussed that clinical aspects of a disease may impact on a 
person’s well-being and adjustment. However, in a number of studies, 
disease characteristics alone do not explain the pattern and variation in 
adjustment and outcome. For instance, in sickle cell disease in children, 
disease characteristics, such as pain and clinical presentation, were found 
to be unrelated to quality of life ratings, suggesting there must be another 
process mediating adjustment (Anie, 2005). The risk and resistance model 
(Wallander & Varni, 1992) uses an umbrella term of ‘stress processing’, 
which incorporates cognitive appraisal as a possible mediating factor.  
Cognitive appraisal refers to the internalised representation and 
explanations of the illness. This aspect of the risk and resistance model is 
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supported by the authors’ own research showing that subjective, and not 
objective, ratings of limb deficiencies influenced adjustment, as measured 
by depressive symptoms (Varni & Setoguchi, 1991). In a more recent study, 
when controlling statistically for certain disease characteristics, attitude 
toward illness was a significant predictor for depression and anxiety 
symptoms resulting from stress (LeBovidge et al., 2005). Another study 
demonstrated that both parent and adolescent attributions were related to 
adolescent adjustment (Guion & Mrug, 2012). Three aspects of appraisal 
(perceived severity, impact and ability to cope) will now be discussed.  
 
1.6.1 Illness appraisal: severity  
Due to inconsistent findings in the association between objective severity 
with illness characteristics, some researchers have suggested that use of 
perceived severity may be more appropriate (Barakat, Lash, Lutz, & 
Nicolaou, 2006). In children (aged 8-15 years) with chronic abdominal pain, 
perceived severity of daily stressors was a strong predictor of outcome 
(depressive symptoms, somatic complaints and functional ability) (Walker et 
al., 2007). Also, children were more likely to employ coping strategies when 
stressors were perceived as more severe. However, severity appraisal was 
a significant predictor of depressive and somatic outcomes even once 
coping had been controlled for through mediational analysis, indicating that 
the appraisal itself, regardless of subsequent action taken, is an important 
factor. Girls were significantly more likely than boys to appraise stressors as 
more severe. This study did not use any report from other sources or 
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objective measures to verify coping or condition presentation, so it is unclear 
how appraisals matched with objective measures of stress and whether 
coping strategies were employed as reported. In children who have 
recovered from cancer, the mother’s appraisal of the threat severity of the 
illness contributed to child’s anxiety and child’s subjective ratings of the 
illness (Stuber et al., 1997). Therefore, it is important to investigate both 
child and parent ratings of severity to examine discrepancies between them 
and the specific effect of parent appraisals on child well-being. Few studies 
have used clinician subjective severity ratings for comparisons.  
 
1.6.2 Illness appraisal- impact 
Another domain within illness appraisal is the perceived impact of the 
illness. This could be on the individual or the family and may include 
financial and social impact, and sense of mastery of condition management 
(Stein & Jessop, 2003). Alternative terms of burden and intrusiveness have 
been used to consider the impact of illness, and include the impact of the 
condition itself as well as related treatment impact or hospital visits. It has 
been suggested that an illness may be perceived as more intrusive when an 
individual feels like they have reduced control and if the illness is more 
severe (Devins, 2010). Illness intrusiveness has been shown to correlate 
with psychosocial outcomes in adults (Devins et al., 1983). For children with 
cancer, their ratings of increased burden as measured on a bespoke scale, 
correlated with lower scores of affect, including both low mood and worse 
anxiety (Currier, Hermes, & Phipps, 2009). The scale created had good 
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internal reliability, although did include items asking about impact on mood, 
which may be confounded with mood measures; they would be expected to 
be correlated. Parents’ ratings of impact may also have an effect. In a study 
of parents of children with epilepsy higher impact ratings were associated 
with higher emotional, cognitive and behavioural problems and worse quality 
of life in children (Camfield, Breau & Camfield, 2001). Higher impact ratings 
were related to objective measures of severity and related to lower 
acceptability of the condition by parents.  
 
1.6.3   Illness appraisal- ability to cope 
In addition to the perception of the illness, the person’s perception of their 
ability to cope is also likely to be important. Lazarus and Folkman’s model 
(1984) identified that it is the discrepancy between demands of a problem 
(primary appraisal) and perceived ability to cope with it (secondary 
appraisal) that determines adjustment outcome. Secondary appraisal or 
‘ability to cope’ has often been termed self-efficacy. Self-efficacy has been 
linked with lower anxiety in chronic conditions (Dalhbeck & Lightsey, 2008), 
better quality of life for those with cancer (Cunningham, Lockwood & 
Cunningham, 1991), fewer self-reported condition-specific symptoms in 
those with diabetes (Griva, Myers, & Newman, 2000), and, in patients with 
sickle cell disease, fewer psychological problems (Clay & Telfair, 2007). 
Self-efficacy may be more concerned with the perceived ability to carry out 
certain illness related behaviours. As there is no significant aspect of self-
management in ITP, the question becomes more “Can I cope emotionally 
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with this condition?”  However, secondary appraisals such as these have 
not been extensively examined in chronic conditions and not in individuals 
with ITP.   
 
In paediatric populations, children may particularly rely on others around 
them, namely their parents, for support. Therefore, parents’ ability to cope 
(or perceived ability to cope) may have a significant effect on child well-
being. Indeed, for mothers of children with asthma, the mothers’ own 
perceived ability to cope was related to child’s quality of life (Sales, Fivush, 
& Teague, 2008). It may also be that child and parent appraisals influence 
each other (Guion & Mrug, 2012).   
 
1.6.4   Illness appraisal in ITP  
Similar to literature discussed above which has reported mixed findings on 
the link between severity of illness and adjustment outcome, Neunert et al. 
(2009) found no correlation between bleeding severity or platelet count with 
HRQoL in children with ITP. This was true for child and parent proxy reports 
and for acute and chronic ITP and suggests that, similar to other 
haematological conditions, it may be how the illness is appraised or 
perceived that has an effect on subjective well-being and outcomes. 
Although a common treatment approach is a ‘watch-and-wait’ approach, this 
may still have significant impact on the individual and family due to constant 
anxiety and regular hospital visits to monitor the condition.  One ITP specific 
quality of life measure (Klaassen et al., 2007) does include questions about 
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what aspects ‘bother’ children with ITP, but no studies have been conducted 
into appraisal of ITP. Adults with ITP have reported differences with their 
clinician in the significance of symptoms of ITP and treatment side effects 
(Guidry, George, Vesely, Kennison, & Terrell, 2009) but no investigation has 
been conducted with children with ITP or their parents. Uncovering a 
discrepancy between clinician and patient ratings of severity or impact may 
highlight an area for intervention. Establishing whether objective disease 
characteristics or subjective experience of the illness is affecting outcome, 
will determine potential support strategies and psychological care for this 
patient group.  
 
1.7 Summary 
Research studies have used several different outcome measures to 
investigate the effect of chronic health conditions on individuals. Research 
suggests that emotional and behavioural functioning, fatigue and cognitive 
functions may be affected. However, these domains have not yet been 
investigated for children with ITP. In a similar way to other physical health 
conditions and specifically blood disorders, and based on patterns seen in 
adults with ITP, differences in these domains would be expected for children 
with ITP. Issues unique to ITP (such as fluctuating platelet count) may exert 
specific effects. Although recent research in children with ITP has begun to 
look beyond clinical outcome, research so far has been limited to quality of 
life measures and there remains a gap in exploring other domains of 
outcome for this population, including psychological measures, and any 
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interaction of variables. Furthermore, the importance of the role of cognitive 
appraisal is discussed widely in the literature in regard to understanding 
adjustment to health conditions but as yet this has not been explored for 
children with ITP.   
 
1.8 The Risk and Resistance Model as Applied to ITP  
It is important to have a theoretical framework to postulate how 
characteristics of the disease, the individual and outcome inter-relate. Here, 
the risk and resistance model (Wallander & Varni, 1992) has been adapted 
to show how factors might interact for children with ITP (Figure 2), taking 
into account the factors discussed above.  
 
In this suggested adaptation, adjustment to ITP is conceived to include 
emotional and behavioural functioning, fatigue and quality of life because 
these were considered to be important areas of adjustment outcome 
identified in paediatric literature and the limited existing research in ITP. As 
discussed, these factors were thought to be inter-related. Cognitive 
functioning has been tentatively added here as a potential adjustment 
outcome. It could also be considered an aspect of the condition itself, 
although the underlying biological mechanism for this is unclear. Platelet 
count and bleeding severity have been included as clinical characteristics in 
the model as these are the current main markers for clinical outcome and 
treatment decision making in ITP. These were expected to correlate with 
adjustment outcome. In the original model, appraisal acts as a moderator 
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between stress and outcome. However, only direct associations between 
appraisal and outcome were explored in the current study. 
 
Figure 2: Suggested Risk and Resistance Model for ITP, adapted from 
Wallander and Varni (1992)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Only factors relevant to the current study have been included in the model 
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In addition, the association between parent and child appraisal was 
explored. Age and gender would be expected to influence adjustment 
outcome directly, as well as through different appraisal styles in boys and 
girls and the effect of different levels of understanding the condition 
dependent on the child’s age.  
 
1.9 Current study  
This study aimed to address significant gaps in the research literature 
relating to children with ITP, which would help develop the treatment and 
support for patients as well as add to our understanding of interaction 
patterns between clinical variables and psychosocial outcome for this and 
other paediatric conditions. This study investigated psychosocial problems 
in adjustment and quality of life for children with ITP and their parents. 
Children with ITP and their parents were approached through routine 
hospital appointments and asked to complete standardised questionnaires 
on levels of fatigue, emotional-behavioural functioning and health related 
quality of life. Parents completed a measure of executive functioning for 
their child, an area completely unexplored in ITP. Use of standardised 
measures allowed for comparisons with children with other physical 
conditions and those without any condition, whilst disorder specific 
measures were included in order to explore the unique characteristics of 
ITP. Children and parents were also asked their appraisal of the child’s 
condition, in line with the suggested role of appraisals as suggested in 
Wallander and Varni’s (1992) theoretical model.  
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The main aim of the research was to establish the psychological profile of 
children with ITP, and determine whether children with ITP have poor 
adjustment outcomes as measured by higher rates of emotional and 
behavioural problems, fatigue and executive function difficulties compared 
with the normal population. Exploratory analyses were made with sickle cell 
populations where this data was available. The study also investigated the 
associations between variables with brief exploration of the demographic 
variables. Finally, the study examined factors that were related to health 
related quality of life. The study did not test theoretical models but used the 
risk and resistance model (Wallander and Varni, 1992) as a framework to 
understand the findings. 
 
The research questions were: 
1. Would children with ITP would display poor levels of adjustment, 
including increased rates compared with the normal population for:  
o Emotional and behavioural problems? 
o Fatigue?  
o Executive functioning difficulties?   
2. How would clinical measures (platelet count and bleeding severity) be 
associated with adjustment variables? 
3. What would be the relationship between outcome adjustment 
variables?   
4. Would more positive appraisal would be associated with better 
adjustment? 
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2 Method  
2.1  Participants  
Children with immune thrombocytopenia (ITP) attending NHS outpatient 
appointments in relation to their condition with their parents/carers were 
eligible for the study. Participants were approached if they had persistent 
ITP (>3 months duration), chronic ITP (>12 months duration), or recently 
recovered ITP (platelet count normal but identified by clinician as having 
ITP, with abnormal blood count in the previous 6 months). Children had to 
be at least 4 years old to be included in the study (using parent report) and 
were eligible to complete self-report measures from the age of five.   
 
Participants were excluded if they had developed ITP as a result of a bone 
marrow transplant as it was felt that the issues presenting in this group 
would be significantly different from the rest of the cohort. For the same 
reason, children were also excluded if they had another medical condition or 
disability that was poorly controlled or active at the time of the study. 
Families with a poor command of English were excluded if an interpreter 
was not already available through the clinic, and/or if language translations 
were not available in the research measures. One family was excluded due 
to language ability; two families were excluded due to the child having co-
morbid condition. In total, 46 families were invited to participate. Figure 3 
outlines the flow of participants through the study.  
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Figure 3: Participant flow diagram 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
In total, at least one questionnaire was returned for 37 families. Thirty-five 
children (M = 10.1 years, SD = 3.47) and 35 parents (M = 43.2 years, SD = 
5.71) participated. This indicates that in the majority of cases (89%), both 
children and parents from the same family chose to participate. Table 1 
summarises the demographics for children and parents that participated. 
There was a significant range in length of diagnosis of ITP between 3 
months and 86 months (8 years), with an average diagnosis length of 32 
months. Six children (16% of the sample) were classified with persistent ITP, 
whilst 31 children (84%) had chronic ITP.   
35 child questionnaires 
and 35 parents 
questionnaires returned 
from 37 families 
46 families 
agreed to 
participate 
49 families had a child 
between 4-16 years with ITP 
and were due to be seen 
within data collection period 
1 family excluded 
on the basis of 
language ability; 2 
families excluded 
on basis of child 
having co-morbid 
condition 
46 families 
eligible and 
approached 
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Table 1: Demographics for participants 
Demographics Participant 
Child  
N=35 
Parent 
N=35 
Gender Male 20 (54.1%) 10 (27%) 
 Female 17 (45.9 %) 22 (59.5%) 
 Missing  3 (8.1%) 
Mean age  
(range, SD) 
10.1 years 
(5-16 years, 3.47) 
43.23 years 
(31-58 years, 5.71) 
Ethnicity  White British 19(54.3%) 15 (40.5%) 
 White other 4 (11.4%) 5 (13.5%) 
 Black African 1(2.9%) 3 (8.1%) 
 Indian 3(8.6%) 2 (5.4%) 
 Pakistani 2(5.7%) 2 (5.4%) 
 Other Asian 
Background 
1(2.9%) 
2 (5.4%) 
 Black African and 
White 
2(5.7%) 
- 
 Asian and White 1(2.9%) - 
 Other Dual 
Heritage 
1(2.9%) 
- 
 Other Ethnic 
Group 
1(2.9%) 
2 (5.4%) 
 Data missing  - 4 (10.8%) 
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2.2  Sample size calculation 
Sample size calculations were based on the main research questions. The 
largest of these calculated samples was 51 and only this calculation is 
reported. This concerned levels of fatigue in child patients with ITP. No 
study has been conducted for fatigue in children with ITP. However, a study 
comparing fatigue scores for those with sickle cell (another blood disorder) 
with a sample from the general population found large effects sizes (0.96) 
for parent reports. Using this in a calculation, 15 participants would be 
required to detect this difference, using a one-tailed t-test of the difference 
between group means, at a power of 80%, and a significance level of 5%. 
However, sickle cell is more severe in symptom presentation and therefore a 
more conservative estimate of effect size was adopted. Using a moderate 
effect size of 0.5, 51 participants would be required under the same test 
parameters. 
 
In order to increase recruitment, a researcher aimed to be at all clinical 
appointments. Clinicians were aware of the study in advance of the start of 
recruitment and attempts were made to schedule appointments, as 
appropriate, within the data collection period. Follow up telephone calls were 
made when questionnaires were not returned. A third clinical site was 
considered but the advantages of increasing sample size were balanced by 
the effect on the heterogeneity of the sample and the changes required to 
the agreed procedure.  
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2.3 Measures  
Measures were chosen which were appropriate to the paediatric population 
being studied, that were relatively brief to self-complete and administer, that 
had the potential to capture both parents’ and children’s perspectives, and 
that covered the age range of interest. Certain measures were favoured for 
their availability of language translations and standardised norms. The 
specific rationale for the measures used is given below. 
 
2.3.1 Total Difficulties (Strengths and Difficulties Questionnaire)  
The Total Difficulties score was taken from four factors of the Strengths and 
Difficulties Questionnaire (SDQ) (Goodman, 1997) (Appendices 1 & 2) and 
used for a measure of emotional and behavioural functioning. This 
combines the scores from the subscales of emotional symptoms, conduct 
problems, hyperactivity/attention, and peer relationship problems. The total 
score can range from 0-40. Use of this score allows comparison with studies 
where scores have not been separated in to individual subscales. Two 
subscales were also used separately in analysis (see below), with totalled 
scores possible between 0-10 for each subscale. 
 
The SDQ allowed for assessment across the whole age range of our 
desired sample using parent report and allowed self-report from young 
people aged 11 years and over. This Total Difficulties score has more robust 
psychometric properties than individual subscales, including better test-re-
test reliabilities (0.72 for parent report, 0.62 for child self-report) and high 
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internal consistency (Cronbach’s α= 0.82 for parent report, α= 0.80 for child 
self-report) (Goodman, 2001), with good discrimination using this score 
between those with a diagnostic disorder and those without (Essau et al., 
2012).  
 
2.3.2 Emotional Symptoms (SDQ) 
Emotional functioning was assessed using the Emotional Symptoms 
subscale of the Strengths and Difficulties Questionnaire (SDQ) (Goodman, 
1997). This subscale combines items about worry, fear and nervousness, 
low mood and somatic symptoms. The subscale has acceptable internal 
consistency in parent and self-reports (alpha values: parent = .67, child = 
.66) (Goodman, 2001; Stone, Otten, Engels, Vermulst & Janssens, 2010) 
and correlates with other measures of emotional functioning (Essau et al., 
2012, Goodman, 2001; Stone et al., 2010). 
 
2.3.3 Conduct  Problems (SDQ) 
The Conduct Problems subscale of the Strengths and Difficulties 
Questionnaire (Goodman, 1997) was used to measure behavioural 
difficulties. This subscale has acceptable internal consistency (parent α = 
.63, child α = .60), stability over time and high specificity for identifying 
individuals without a relevant mental health diagnosis (Goodman, 2001).  
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2.3.4 Pediatric Quality of Life InventoryTM (PedsQLTM): 
Multidimensional Scale for Fatigue   
The 18-item Pediatric Quality of Life InventoryTM (PedsQLTM): 
Multidimensional Scale for Fatigue (Varni, Burwinkle, Katz, Meeske, 
Dickinson, 2002) was used to measure fatigue (Appendices 3-5). This has 
good internal consistency (alpha, α = .95 child report, .95 parent report). It 
covered the full age range of the study population (for parent report), and 
allowed children over five years old to self report (5-7 year olds were 
assisted by interviewer). It has been developed specifically for assessing the 
quality of life of children with health conditions. A higher score indicates 
lower problems with fatigue.  
 
2.3.5 Behaviour Rating Inventory of Executive Functioning (BRIEF)   
Executive function difficulties were measured using parent informant report 
on the 86-item Behaviour Rating Inventory of Executive Functioning (BRIEF) 
(Gioia, Isquith, Guy & Kenworthy, 2000a) (Appendix 6). This was preferred 
to cognitive testing due to the time that would have been required to 
complete cognitive tests and it was not felt this was appropriate for the 
study. This measure has good reliability, with high test-retest reliability (.82 
for parents) and internal consistency (α = .98) (Gioia, Isquith, Guy & 
Kenworthy, 2000b). 
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2.3.6 Kid’s ITP Tools (KIT)   
The Kid’s ITP Tools (KIT) (Klaassen et al., 2007) (Appendices 7 & 8), an 
ITP-specific quality of life measure for children, was administered. This 
questionnaire includes items about emotional and physiological symptoms, 
which allowed comparisons with other measures in this study, as well as 
specific concerns and issues around ITP such as bloods tests, bruising and 
potential worries around platelet count. Two versions, assessing quality of 
life from the child’s perspective and child’s quality of life from the parents’ 
perspective were used. This has been shown to have acceptable test-retest 
reliability (Intra-class correlation > 0.70) (Klaassen et al., 2007).  
 
2.3.7 Visual Analogue Appraisal Scales (Appendices 9-11) 
Visual analogue scales (VAS) were constructed to investigate both parents’ 
and children’s cognitive appraisals of ITP. These were constructed using 
adapted items primarily from the Child Attitude Towards Illness Scale 
(CATIS, Austin & Heberty, 1993), the Uncertainty in Illness Scale (Mullins & 
Hartman, 1995), and the Parent Experience of Child Illness Scale (PECI, 
Bonner et al., 2006). These measures were felt to be inappropriate for this 
study due to their length and the specific wording of certain items. 
Construction of the VAS measure was done in consultation with three 
project supervisors, all Clinical Psychologists, and a Haematology 
Consultant.  
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Two VAS forms were created for children- one for children aged 5-6 and the 
other for children aged 7-16 years. For the older children (7 years and older) 
and parents, the visual analogue scales covered the child and parent’s 
subjective severity rating of the condition, its impact and their perceived 
coping ability. Wording was kept consistent across parent and child scales 
and all items were on a five point (0-5) Likert scale. There was also a space 
available for qualitative report of the aspect of ITP that ‘bothers you the 
most’. This terminology was selected as it is also used in the Kids ITP Tools 
(Klaassen et al., 2007). The VASs were trialled with two 11 year olds from a 
non-clinical population. They confirmed that the format made sense and no 
further amendments were made. Younger children (5-6 years) completed a 
simplified version which included how bad they would rate their illness using 
a 5-point Likert scale with faces and the aspect of ITP that bothers them the 
most. This format was chosen because it is the same as the version of the 
PedsQLTM Multidimensional Fatigue Scale (Varni et al., 2002) for children 
aged 5-7 years. 
 
2.3.8  Demographic and clinical factors 
Demographic information was obtained through the questionnaires or the 
clinical file and included gender, age and ethnicity for child and parent. 
Clinical factors were obtained from clinical records and included platelet 
count, bleeding severity, previous and current treatment course and side 
effects, length of diagnosis, co-morbid conditions, and the occurrence of a 
previous intracranial haemorrhage (Appendix 12 – clinical record form). 
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Platelet count and bleeding severity were rated from results from the most 
recent clinic attendance or the most recent blood results on file from the 
General Practitioner or other clinical site. Bleeding severity was judged 
using the standards from the Intentional Consensus Report on ITP 
management (Provan et al., 2010). This was used as it drew on several 
research developments of the topic, gave clear descriptors for clinicians and 
distinguished between minor and mild symptoms at the lower end of the 
symptom scale, applicable to the child population. Clinicians also gave a 
subjective rating of severity of illness based on their perception of the overall 
severity for the child, over the whole course of the illness, since diagnosis.  
 
2.4  Administration of questionnaires 
The order of the questionnaires was kept the same for all participants (within 
each age range). The order was: Strengths and Difficulties Questionnaire 
(Goodman, 1997), PedsQLTM Multidimensional Fatigue Scale (Varni et al., 
2002), KIT (Klaassen et al., 2007), BRIEF (Gioia et al., 2000a) (parents 
only), visual analogue scale. The reason for this order was to prioritise the 
gathering of the SDQ data as our main outcome measure and also to take 
into account the demand and acceptability to the participants (not including 
the longest measure first or last).  
 
The questionnaires given to each child and parent varied depending on age 
of the child. This is summarised in Table 2. Child questionnaires were 
estimated to take up to 15 minutes, although this was less for young 
64 
children who had fewer measures. This was verified with two 11 year olds 
from the general population prior to commencement of the study and was 
accurate to completion times observed in clinic. 
Table 2:Summary of measures given to participants, dependent on child age 
Note. KIT= Kids ITP tools; PedsQL
TM
-Fatigue= Pediatric Quality of Life Inventory
TM
  
Multidimensional Scale for Fatigue; SDQ= Strengths and Difficulties Questionnaire; BRIEF= 
Behaviour Rating Inventory of Executive Function 
 
  Measures 
Age of 
child 
(years) 
Participant Visual 
Analogue 
Scale 
KIT PedsQLTM-
Fatigue 
SDQ BRIEF 
5-6  
Child      
Parent      
  
     
7  
Child      
Parent      
 
      
8-10  
Child      
Parent      
  
     
11-16  
Child      
Parent      
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Parents were given five questionnaires, regardless of child age. The only 
difference between parent questionnaires was the versions of the fatigue 
scale, which were different dependent on the age of the child (four age-
range versions). The questionnaires took approximately 15-20 minutes for 
parents to complete.  
 
2.5  Procedure  
The research was conducted through paediatric haematology clinics in two 
NHS hospital sites in London. Potential participants were first made aware 
of the study through correspondence with their clinician or during their clinic 
appointment. Advertising materials (Appendix 13) were also displayed at 
one of the clinic sites. A member of the research team then approached 
families who were attending their routine clinic appointments. The 
researcher explained the project and obtained informed consent.  
 
Information sheets were given to children and parents (Appendices 14-16). 
The purpose and procedure of the study was outlined clearly. For child 
participants, verbal or written assent (Appendix 17) was obtained from those 
5-15 years old, with written parental consent. Young people aged 16 years 
and over and parents gave written consent for themselves (Appendices 18 
and 19).  Parents were allowed to participate if their child did not want to 
complete questionnaires; children were allowed to participate (with parental 
consent) if their parents declined to be participants themselves. There were 
two instances of children participating where parents did not return 
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questionnaires. There was one family where the parent completed 
questionnaires and the child declined, and an additional one family where 
only the parent participated due to age of the child.  
 
Parents and children were then given questionnaire measures to complete 
by the Chief Investigator, who was available in person to answer any 
questions. Where participants did not have a good command of English, 
translated measures were used if available or an interpreter was used if 
present already through the clinic appointment. An interpreter was used with 
three families. The Arabic version of the SDQ was offered to one parent, but 
instead they expressed a preference for translation of the English version 
through an interpreter available. The SDQ French version was given to one 
parent (child of the same family used the English version) but this parent 
was happy and able to use the English versions of the other measures.  
 
Families often had to wait for blood tests and results, which allowed time for 
the completion of questionnaires in clinic. If completing measures on site, 
families had the option to complete in a private clinic room with the Chief 
Investigator present or in the waiting area. Children were not separated from 
their parents. A prompt was given to parents and children to not discuss 
their responses until completion, where this was observed to be occurring. 
Families also had the option of taking the measures away and returning 
them by post. On four occasions, due to the timing of clinic appointments, 
families were contacted by phone about the research after initial introduction 
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from the clinical team and questionnaires were sent out by post. Participants 
were contacted three weeks after receiving questionnaires to prompt their 
completion and answer any outstanding questions regarding the study, as 
explained in the information sheet for the study.   
 
Demographic information about the child and adult participant was obtained 
through a self-report questionnaire completed by parents (Appendix 20) 
and/or through the clinical notes, with consent. Clinical information on 
disease related factors was obtained from patient records via the clinical 
team with explicit consent from relevant party (young person or parent). 
Researchers outside of the clinical team did not have direct access to 
clinical records. Clinical information was provided on separate forms and 
linked to questionnaire responses by means of a unique indentifying code. 
Data collected was stored in line with University, NHS (local and national) 
and professional guidelines and policies.  
 
Parents and young people were asked if they would like to be contacted 
regarding the results. Where this offer was accepted, families provided 
contact details, typically in the form of an email address. Thirty-three families 
requested this summary.  
 
68 
2.6 Ethical Considerations and Approval  
The study was approved by Royal Holloway Research Ethics Committee, 
NHS Research Ethics Committee, an additional research governance 
committee associated with the lead hospital site and other local site 
approvals including from the two NHS Trust Research and Development 
Departments (Appendices 21-26).  
 
The procedure was assessed to not be too demanding on participants, both 
in terms of time and nature of the questions asked. Families appeared 
happy to complete questionnaire and no distress was observed through 
completion. Participants were given the full rationale for the study, with no 
deception employed. Information sheets were constructed for different age 
ranges of children to facilitate understanding of the project.  
 
2.7 Service User Involvement  
Service user involvement results in better quality research that is meaningful 
and of interest to the population and wider society the research serves 
(INVOLVE, 2012). Furthermore, involving service users in research fosters a 
sense of empowerment and respect, and this may be particularly significant 
for children, who may feel their opinions are not always taken in to 
consideration. Best practice guidance (Department of Health, 2005) states 
that service users should be involved at each stage of research where 
possible and funding and ethics boards now require careful consideration of 
how and when service users may be involved.  
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For this study, the concepts and themes to be investigated were highlighted 
at a one day joint patient convention and professional conference run by the 
ITP Support Association in April 2014, prior to finalising the research 
procedure. This was to assess whether the broad research themes were of 
interest and relevance to people who had experience of ITP. This was 
attended by the Chief Investigator (doctoral student) and a Haematology 
Consultant from one of the hospital sites. Attendees were not aware of our 
attendance prior to the event but discussion took place on an ad hoc basis, 
with agreement from the organisers and in keeping with the format and 
expectations of the event.  Discussions were had in small groups, one group 
which was specifically for children with ITP and/or their parents. Subsequent 
discussions took place on the day with individuals, as they volunteered 
themselves. The idea behind the research was well received. In particular, 
attendees with ITP (and their family members) seemed interested in the 
area of fatigue and this was reported as a major problem for adults and 
children with ITP.  
 
Members of the public (without ITP) and a child with ITP and their parent 
provided feedback on materials used in the study. Amendments included 
minor changes to wording and structure to make documents more 
accessible and clarify what was being asked of participants. One young 
person approached in clinic for participation expressed a particular interest 
in the study and was subsequently contacted to help construct an 
accessible summary of the results (Appendix 27). 
70 
2.8 Analysis plan 
 
2.8.1 Preparation of data.  
Scores on all measures were examined for normality using calculated 
figures for skew and kurtosis, and by visual inspection of the data in 
graphical format. The data was also inspected for outliers and, where 
relevant, calculations were made to determine the extent of discrepancy of 
the outlier from the mean. Negativity and inconsistency scores were 
examined to check validity of responses on the BRIEF measure (Gioia et al., 
2000a); a score of 5 or above for negativity was considered high. This could 
indicate responder bias or high executive problems for the target child. On 
the inconsistency scale for the same measure, a score of 6 or less was 
considered within acceptable bounds.  
 
For the Strengths and Difficulties Questionnaire (Goodman, 1997), each 
sub-scale has five items contributing to it. Items were scored from 0 (not at 
all true), 1 (somewhat true), or 2 (certainly true). Each subscale score can 
range from 0 to 10. Pro-rata values were used for missing values where at 
least three scores were present (i.e. no more than two missing values) for a 
particular scale. For the BRIEF measure, in accordance with the protocol 
suggested in the manual (Gioia et al., 2000a), for subscales with one or two 
missing values, missing values were replaced with a score of 1. Where more 
than 2 scores were missing, T scores were not calculated for the subscale 
or any derived scores. For the PedsQLTM-Multidimensional Fatigue Scale 
(Varni et al., 2002), scores were not computed if more than 50% of the items 
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were missing from a particular scale. For the KIT summary score to be 
calculated, no more than 6 items could be omitted.  
 
2.8.2 Categorisation of scores.  
SDQ scores were considered in a four band categorisation: ‘Close to 
average’, ‘slightly raised’, ‘high’ and ‘very high’ (Goodman, 2013). ‘Abnormal 
scores’ are described as falling within the latter three categories. 
Approximately 80% of the child population have scores ‘close to average’, 
whilst only 5% of children would have scores in the ‘very high’ range. BRIEF 
values were converted in to T scores, which are linear transformations of 
raw scores, allowing comparison with a standardised sample. Scores of 65 
or higher (+1.5 SD from the mean) were considered to indicate problems 
with executive function. In line, with scoring instructions, low fatigue scores 
represented worse fatigue. 
 
2.8.3 Analyses. 
Data was analysed using Statistical Software for Social Scientists (SPSS) 
version 21. Unless otherwise stated, alpha value for significance was 
considered as p < 0.05. T-tests were carried out to explore gender 
differences and answer the questions concerning the difference of data 
scores from published comparable samples and normative values. Where 
study scores were compared to published norms or data from another 
sample, GraphPad software (Motulsky, 2015) was used to test this 
difference. Correlation coefficients were calculated to test the association 
between variables. This was used to address the research question 
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regarding clinical condition factors (including platelet count) and adjustment 
variables, and the relationships between fatigue, executive functioning, 
emotional-behavioural functioning, appraisal and quality of life. Associations 
within each measure (i.e., between subscales) are not discussed. 
Qualitative comments from the KIT and VAS were reviewed and themes 
extracted.  
 
3. Results 
After description of the normality of the data and reliability of the Visual 
Analogue Appraisal Scale, results are presented in four main parts. The first 
discusses demographic and clinical information and explores the 
relationship of age and gender with the outcome variables. For fatigue, 
groups were also examined on the basis of active treatment. The second 
part of the results examines the main research questions concerning 
difference in outcomes of children with ITP compared with healthy children 
and children with sickle cell disease (SCD). The third part examines the 
relationship between variables, firstly testing the association between 
clinical information and adjustment outcomes and then the inter-
relationships between adjustment outcome variables. Finally, appraisal and 
qualitative comments are explored. Where measures were completed by 
both parent and child, these are discussed in turn.  
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3.1 Normality  
Inspection of all measures, except the platelet count, showed the scores to 
be normally distributed, with measures for skew and kurtosis within normal 
bounds. Applying a square root transformation of the platelet count returned 
values to acceptable bounds. Outliers were identified within some 
responses but these were within three standard deviations of the means for 
these scales.  
 
3.2 Visual Analogue Appraisal Scale - Reliability and Validity  
The Visual Analogue Appraisal Scale for parents (five items) and the 
children’s scale (1 or 3 items, depending on age) were tested for internal 
consistency using Cronbach’s alpha. The parent scale was shown to have 
good internal consistency (α = .81). Analysis showed that removing any of 
the items, except parent’s rating of child’s coping would decrease this alpha 
value.  Removing the ‘child coping’ item would increase reliability to .83. 
This item also correlated poorly with other items, which could suggest it 
should be removed. The child scale showed a poor level of reliability (α = 
.65). Analyses indicated that removing the item of child’s rating of their own 
coping would increase the scale’s reliability to .87, a good level of reliability. 
This demonstrates that items from each scale are related and seem to be 
measuring the same overall construct. These results confirmed that scores  
from this scale could be used the main analyses.    
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Parents’ rating of the amount their child’s life was affected as rated on the 
Visual Analogue Appraisal Scale (VAS) was significantly associated with 
parents’ quality of life rating for child ( r(30) = -.47, p = .006), which supports 
the construct validity of this item of the VAS. There was a similar correlation 
on the child rating of their quality of life with their rating on the VAS of the 
extent their life affected ( r(22)= -.44, p = .03).  
 
3.3 Demographics 
Information for the children with ITP is presented in Table 3. The sample 
was an approximately equal split of girls and boys (17 girls, 20 boys). The 
average age was 9.84 years (SD= 3.61). Most children (84%) had chronic 
ITP (of duration over 12 months), with the average length of diagnosis as 
31.9 months (range = 3-96 months). The average platelet count was 84.2 
(x103 platelets / micro litre) (SD = 80.54, Range = 1-286). Seven children 
had counts over 150 (x103 platelets / micro litre). As discussed, it was 
confirmed that these children had abnormal counts within the last six 
months. Bleeding severity as rated by clinicians was generally low, with only 
one patient rated as moderate bleeding severity; the remaining children had 
minor-mild bleeding or no bleeding.  
 
Most children (78.4%) were not receiving active treatment. Of those on 
treatment, no side effects were observed or reported. Thirteen children 
(35.1%) had never had previous active treatment.  Only one child had 
previously had an intra-cranial bleed. Eleven children (30% of sample) had 
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other conditions. Some children had more than one co-morbid condition. 
These were all judged clinically to be well-managed and stable. Three 
children were also identified as having conditions previously, including 
previous vitamin D and iron deficiency, recurrent tonsillitis, and CMV 
infection. 
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Table 3: Demographics and clinical data for the sample of children with ITP 
Characteristic Number of children (%) 
N= 34 
ITP type  
     Persistent  6 (16) 
     Chronic 31 (84) 
Current treatment (%)  
     No active treatment 29 (78.4) 
     Tranexamic acid 3 (8.1) 
     IVIG 1 (2.7) 
     Rituximab 1 (2.7) 
     Combination  1 (2.7) 
     Other 2 (5.4) 
Other conditions a  
     Asthma 2 (5.4) 
     Diabetes 1  (2.7) 
     Eczema/ Dermatitis  2 (5.4) 
     Evan’s syndrome 2 (5.4) 
     Klinefelters and congenital talipes  
          equinovarus 
1 (2.7) 
     Mild IgA and IgM deficiency 1 (2.7) 
     Mild undefined joint pain 1 (2.7) 
     Molluscum 1 (2.7) 
     Recurrent tonsillitis 1 (2.7) 
     Rhinitis  1 (2.7) 
     Undiagnosed gastrointestinal problems  1 (2.7) 
Previous ICH bleed 1 (2.7) 
a Some children had a combination of more than one co-morbid condition 
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Demographic information of age and gender was examined across the 
various adjustment measures in order to determine their significance in the 
analyses relating to the main research questions.  
 
Mean scores for each gender on emotional and behavioural difficulties 
(Emotional Symptoms, Conduct and Total Difficulties) from the Strengths 
and Difficulties Questionnaire are displayed in Table 4.  
 
Table 4: Gender comparisons for total subscale scores on the Strength and 
Difficulties Questionnaire (SDQ), averaged across participants 
 Boys Girls   
SDQ Subscale M SD M SD t df 
 Child Self report   
 N= 9 N=8   
Emotional Symptoms 2.00 1.50 4.0 1.77 -2.52 15 
Conduct Problems 2.22 1.39 1.75 1.28 0.72 15 
Total Difficulties Score 9.0 5.5 8.88 4.42 0.05 15 
 Parent proxy-report   
 N=19 N=16   
Emotional Symptoms 2.74 2.16 3.63 1.78 -1.31 33 
Conduct Problems 2.26 1.82 1.81 1.33 0.82 33 
Total Difficulties Score 10.84 6.78 9.75 4.85 0.54 33 
Note. SDQ subscale scores can range from 0-10; SDQ Total Difficulties score can 
range from 0-40.  
*Test significant at .05 level (2-tailed). **Test significant at .01 level (2-tailed). 
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For parent ratings, no subscales showed significant differences for gender. 
For child ratings, there were no significant differences based on gender for 
Conduct Problems or Total Difficulties. The Emotional Symptoms subscale 
showed a significant difference for the two genders, with girls reporting 
significantly more problems.  
 
Age was negatively correlated with the Emotional Symptoms subscale of the 
SDQ for parent ratings (r(33) = -.375, p = .027), indicating older children 
were reported to have fewer emotional problems. There were no 
correlations for any of the SDQ scales with age for the children’s ratings.  
 
There were no significant differences between boys and girls on fatigue 
measures, for both parent and child ratings (Table 5). Individual Pearson’s 
correlations were carried out between age and fatigue scores. Due to 
multiple comparisons (eight comparisons) across subscales, a p value of 
0.0063 was selected. The only scale that approached significance was 
sleep fatigue as rated by children (r(32) = –.45,  p = .007).  
 
To investigate whether findings would be analogous to those found with 
adults with ITP and fatigue (Newton et al., 2011), analysis was carried out 
on the sample to determine if there were any differences in fatigue between 
those on treatment and those not on active treatment. Those on treatment 
(seven children) experienced significantly worse total fatigue than those on 
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observation only (t(32) = 2.98, p = .005), as rated by parents but there were 
no differences between child ratings (t(32) = 1.78, p = .084).  
 
Table 5: Mean subscale scores of fatigue for boys and girls 
Note. A higher score indicates lower problems with fatigue 
a n = 15 girls 
 
Visual examination of the executive functioning data (from the BRIEF) 
showed different patterns of scores for girls and boys (Figure 4). Boys 
showed heightened problems around the age of 7 years and around 13 
 Boys Girls   
Subscale M (SD) M (SD) t df 
 Child self-report   
 N=18 N=16   
Total fatigue  71.67 (14.71) 68.54 (17.23) 0.57 32 
General fatigue a 79.17 (12.78) 67.22 (22.38) 1.92 31 
Sleep fatigue 65.19 (20.73) 69.48 (17.59) -0.65 32 
Mental fatigue  70.60 (23.50) 69.53 (21.18) 0.14 32 
 Parent proxy-report   
 N=19 N=15   
Total fatigue  66.76 (19.90) 68.61 (14.52) -0.30 32 
General fatigue  67.02 (19.57) 67.22 (18.69) -0.03 32 
Sleep fatigue 68.20 (19.31) 68.06 (15.80) 0.02 32 
Mental fatigue  65.35 (28.50) 70.56 (18.80) -.64 32 
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years. Girls showed high problems around age 8 and some elevation at a 
later age (age 12) but not to the extent seen in boys. These patterns should 
be considered with caution as often only 1-3 data points contributed to each 
age for each gender. However, the patterns parallel those reported by the 
authors of the scale, who commented on an interaction pattern between age 
and gender where boys experienced greater problems with executive 
function that decreased with age (Gioia et al., 2000b). Considering this 
information, and to allow comparison with published comparison 
scores/norms, T scores (linearly transformed scores relative to a 
standardised sample) were calculated and used in statistical analyses.   
Figure 4: Global executive functioning by age and gender 
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Analysis of the effect of gender on quality of life scores (Table 6), indicated 
no significant difference of gender for parental reports (t(31) = 0.266, p = 
.792) or child reports (t(22) = 1.62, p = .119). There was no correlation of 
age with quality of life for parent (r(31) = 0.253, p = .155) or child ratings (r 
(22) = 0.098, p = .648)  
 
Table 6: Mean (SD) quality of life scores from Kids ITP Tools (KIT) 
 
Parent proxy  
KIT score 
 Child self-report 
 KIT score 
Male Female  Male Female 
N=19 N=14  N=12 N=12 
 
 
   
78.77 
(14.99) 
77.40 
(14.19) 
 
84.03 
(12.55) 
74.73 
(15.43) 
 
 
In summary, only limited associations were found between demographics of 
age and gender with study variables. These included a gender difference on 
Emotional Symptoms and a trend association with age and fatigue. As the 
current sample comprised approximately equal numbers of girls and boys it 
was still appropriate to carry out the planned analyses as a single combined 
group. Also, dividing the group would have resulted in smaller samples and 
may have increased the chance of Type II error in the study. The 
associations of age and gender for BRIEF scores were controlled through 
conversion of raw scores to T scores.  
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3.4 Profile of adjustment in ITP: Comparison with Other Samples 
3.4.1 Total difficulties (emotional and behavioural functioning).  
For parental report, most children were rated as not having difficulties with 
emotional and behavioural functioning. However, 14.4 % of children (5 
children) were rated in the high-very high range on total SDQ score, 4 of 
these (11.5% of valid sample) were rated in very high range. By 
comparison, only 5% of children in the normal population have scores in this 
very high range (Goodman & Goodman, 2011). For child reports, the total 
SDQ score for two children fell within an abnormal range, with one classed 
as slightly raised, and the other as very high.  
 
In order to establish whether emotional and behavioural difficulties were 
significantly higher in this sample of children with ITP compared with the 
normal population in line with research questions, t-tests were carried out. 
Normative values published in a study by the Office of National Statistics 
(Meltzer, Gatward, Goodman, & Ford, 2000) were used for comparison 
(Table 7). In order to use a comparative sample, only reports from parents 
relating to 5-15 year olds were used for this analysis (4 year olds and 16 
years olds were excluded). Normality checks were re-run on this sample. All 
scores were within acceptable bounds, with no display of skew. Total 
Difficulties score rated by parents was significantly different from normative 
values (t(10328)= 2.4102, p = .02). This was a small to moderate effect size. 
Child self-report scores of Total Difficulties were not significantly different 
from normative values (t(4243) = 1.0756, p = .28). These results indicate 
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that children with ITP did have higher rates of emotional and behavioural 
difficulties compared to healthy children based on parental report of 
difficulties, but not on child ratings of difficulties. In order to examine this 
result in more detail, Emotional Symptoms and Conduct Problems 
subscales were also compared to the normative values.  
 
Table 7: Comparisons of parent and child mean scores on Strengths and 
Difficulties subscales with normative values  
Note. d=effect size (Cohen’s d) 
*Test significant at the 0.05 level (2-tailed). **Test significant at the 0.01 level (2-tailed). 
 
 ITP sample Normative 
comparison 
   
Subscales M S.D M S.D t df d 
 Child self-report    
 N=14 N=4228    
Emotional Symptoms 2.43 1.45 2.8 2.1 0.66 4240 0.18 
Conduct Problems 2.00 1.24 2.2 1.7 0.44 4240 0.12 
Total Difficulties Score 8.5 4.62 10.3 5.2 1.29 4240 0.35 
 Parent proxy report    
 N=32 N=10298    
Emotional Symptoms 3.25 1.97 1.9 2.0 3.81** 10328 0.68 
Conduct Problems 2.19 1.61 1.6 1.7 1.95 10328 0.35 
Total Difficulties Score 10.88 5.78 8.4 5.8 2.41* 10328 0.43 
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3.4.2 Conduct problems.  
Six children (17.2%) were rated by their parents to have conduct problems 
that were in the high-very high range, although only one of these was in the 
very high range. Three children rated themselves as having problems with 
conduct that could be considered ‘slightly raised’. No children reported 
problems that reached the high level of problems. As seen in Table 7, the 
difference on the SDQ subscale for Conduct was close to significant for 
parent ratings. This was a small to medium effect size and the finding of no 
statistical significance should be considered with the small sample size. 
However, these results indicate that behavioural problems were not higher 
for this sample.  
 
3.4.3 Emotional functioning. 
Just over half the children (51.4%) were rated by parents as having scores 
on the Emotional Symptoms subscale within the ‘close to average’ range, 
22.9% scored in the ‘slightly raised’ range, 25.8% (a quarter of valid sample) 
in the ‘high’ or ‘very high’ range (only one person scored as very high). 
Parental reports of emotional difficulties were significantly higher for the ITP 
group than normative values (t(10328) = 3.81, p = .001) (Table 7). This was 
a medium to large effect. Two children rated their emotional symptoms as 
above normal, with one categorised as high, the other as very high. 
Children’s ratings of their own emotional symptoms, as reported on the SDQ 
was not significantly different from the normative comparison group. Related 
to the first research question, this shows that Emotional Symptoms were 
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worse for a larger proportion of children with ITP, compared with a normal 
population but based on parents’ ratings only.  
 
3.4.4 Fatigue.  
In order to examine the first research question in relation to fatigue, fatigue 
scores for this sample were compared from those for healthy controls taken 
from data published by Panepinto and colleagues (Panepinto et al., 2014). 
Table 8 shows the means for the both samples. As discussed, higher fatigue 
scores indicate lower problems. There were significant differences on both 
total and all subscale scores for fatigue, between ITP participants and 
healthy controls, for both parent and child ratings. The effects sizes for 
these ranged from small (for sleep fatigue as rated by children) to large (for 
general, sleep and total fatigue ratings from parents). In answer to the first 
research question, this indicates that within the sample, children with ITP did 
have greater levels of problems with fatigue compared to healthy children. 
Effects were larger depending on person reporting (parent or child), with 
parent reports generally showing larger effects. Two parents additionally 
commented elsewhere in the questionnaire packs that tiredness or energy 
levels were a particular issue for their child/the issue that bothered them as 
parents the most.  
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Table 8: Comparison of mean fatigue scores in children with ITP and 
healthy children 
 
Note. d = effect size (Cohen’s d). A higher score indicates lower problems with 
fatigue 
a n = 33.  
*Test significant at the 0.05 level (2-tailed). **Test significant at the 0.01 level (2-
tailed). 
 
 
 ITP sample Healthy 
sample 
   
Measure M SD M SD t df d 
 Child Self report    
 N=34 N=209    
Total fatigue  70.20 15.78 81.8 12.5 4.83** 241 0.62 
General fatigue a 73.74 18.50 86.1 13.6 4.60** 240 0.60 
Sleep fatigue 67.21 19.15 76.8 16.3 3.10** 241 0.40 
Mental fatigue  70.10 22.11 82.4 16.5 3.83** 241 0.50 
 Parent proxy-report    
 N=34 N=209    
Total fatigue  67.58 17.50 88.2 11.1 9.42** 291 1.10 
General fatigue  67.11 18.90 88.8 12.3 9.00** 291 1.10 
Sleep fatigue 68.14 17.58 87.6 13.5 7.61** 291 0.90 
Mental fatigue  67.65 24.49 88.2 16.0 6.56** 291 0.77 
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As an exploratory analysis, scores for fatigue from this study were compared 
with a sample of children with sickle cell disease from a published study 
(Panepinto et al, 2014). There were no significant differences between 
parent rated scores on the total fatigue score or any fatigue subscale. 
However, there were significant differences between child ratings of fatigue 
between those with ITP and those with sickle cell, on total and all subscale 
measures, with children with ITP rating themselves as less fatigued. (total 
fatigue, t (272) = 2.57, p = .01, general fatigue, t(271) = 2.02, p = .04, sleep 
fatigue,  t(272) = 2.15, p =.03, mental/cognitive fatigue, t(272) = 2.33, p = 
.02). In relation to the first research question, concerning fatigue levels in 
children with ITP, it seems that although fatigue levels were higher than 
healthy children, they may be the same or better compared with children 
with sickle cell disease. 
 
3.4.5 Executive functioning.  
BRIEF scores were examined on two validity checks available as part of the 
measure. One person scored 5 on the Negativity check. This could indicate 
the responder parent is negatively biased in their responding style or reflect 
a real and substantial deficit for the child being commented on. Examination 
of inconsistency scores indicated that all respondents were classified as 
within acceptable bounds of consistency.  
 
Five children (16.5%) had T scores of 65 or over on the Behaviour 
Regulation Index. Six children (19.9%) had T scores of 65 or above for 
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Meta-cognition Index. Six children (19.9%) had T scores of 65 or above for 
Global Executive Composite. In order answer the first research question, 
overall executive functioning scores (Global Executive Composite) were 
compared with normative values using t-tests (Table 9). In comparison, 
there were significant differences on Global Executive Composite Score, 
indicating possible higher rates of difficulties in executive functioning for this 
sample of children with ITP. Removing the case with elevated ‘Negativity’ 
score from analysis, this difference remained statistically significant, (t(1446) 
= 2.11, p = .035). In answer to the first research question, there appeared 
greater executive functioning problems for children with ITP. However, this 
was a small to moderate effect, and reflects that a large proportion of the 
sample (80%, 25 children) had scores within a normal range. Post-hoc 
examination of other scores revealed that executive functioning measured 
on Emotional Control and Initiation subscales, and the Behaviour Regulation 
Index were also significantly worse for this group (t(1448) = 4.86, p  < 0.001; 
t(1448) = 2.21, p = 0.03; t(1447) = 3.06 , p = 0.002, respectively). There was 
a small to moderate effect size for presence of ITP on Initiation but 
moderate and large effect sizes for Behaviour Regulation and Emotional 
Control, respectively.  
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Table 9: Comparisons of mean executive functioning (BRIEF) scores with 
normative t-test values 
Note. BRIEF= Behaviour Rating of Executive Functioning; d = effect size 
(Cohen’s d) 
a n = 30 
*Test significant at the 0.05 level (2-tailed). **Test significant at the 0.01 level (2-
tailed). 
 
 ITP sample Healthy 
sample 
   
Scale M SD M SD t df d 
 N= 31 N=1419    
Inhibit 52.07a 11.55 50 10 1.12 1447 0.21 
Shift 53.06 10.64 50 10 1.69 1448 0.31 
Emotional Control 58.87 12.15 50 10 4.86** 1448 0.88 
Behaviour 
Regulation 
55.67a 11.67 50 10 3.06** 1447 0.57 
Initiate 54.03 11.67 50 10 2.21* 1448 0.40 
Working Memory 53.19 10.17 50 10 1.76 1448 0.32 
Plan/Organise 51.73a 11.69 50 10 0.94 1447 0.17 
Organisation of 
materials 
53.10 9.33 50 10 1.71 1448 0.31 
Monitor 51.97 10.64 50 10 1.08 1448 0.20 
Meta-cognition 
Index 
52.70a 11.04 50 10 1.46 1447 0.27 
Global Executive 
Composite 
54.37a 11.63 50 10 2.36* 1447 0.44 
90 
Exploratory t-test analysis was carried out to examine the profile of 
executive function abilities compared with a sample of children with sickle 
cell disease (Hensler et al., 2014). To make the best comparison with the 
age range of the sample of children with sickle cell disease, only scores for 
children aged over 8 years were selected from the current sample.  No 
significant differences were found on Indices of Behavioural Regulation, 
Meta-Cognition or Global Executive Composite for this sample compared to 
a comparative sample of children with sickle cell (Table 10).  
 
Table 10: Comparisons of BRIEF scores between ITP participants and 
children with sickle cell disease (SCD)  
 ITP sample 
N=21 
SCD sample 
N=20 
  
 M (SD) M (SD) t df 
Behaviour 
Regulation 
53.0 (10.63) 54.3 (14.4) 0.33 39 
Meta-cognition 50.48(10.67) 55.3 (13.3) 1.28 39 
Global Executive 
Composite 
51.67 (10.80) 55.2 (13.9) 0.91 39 
 
3.5 Association between variables  
Investigated variables were tested for associations using Pearson’s bivariate 
correlations (Tables 11-13) to answer the second and third research 
questions. 
 
91 
3.5.1 Disease characteristics with adjustment outcome.  
Neither bleeding severity nor platelet count were significantly correlated with 
any of the fatigue scales for parents’ or children’s ratings (Table 11, Table 
13). For parent ratings, neither bleeding severity nor platelet count score 
was significantly correlated with any of the Strengths and Difficulties 
Questionnaire scales.  
 
For child ratings (Table 12), bleeding severity was highly negatively 
correlated with Conduct Problems (r(15)= -.64, p = .005) and Total 
Difficulties (r(15) = -.64, p = .006) on the Strengths and Difficulties 
Questionnaire. Higher bleeding severity was related to lower problems in 
emotional and behavioural functioning. As only one child had a bleeding 
severity of 3 (moderate), it may be that their low scores on the SDQ may 
have skewed these results. However, removing this case, the association 
between bleeding severity and these SDQ scores remained (Conduct, r(14) 
= -.56, p = .02; Total Difficulties, r(14) = -.66, p = .006).  
 
3.5.2 Associations between adjustment outcome variables.  
Correlations were used to answer the third research question, regarding the 
associations between adjustment variables. Emotional functioning was 
negatively correlated to two (of the three) fatigue subscales (sleep fatigue 
and mental fatigue) and total fatigue (Table 11). As a higher fatigue score 
represents fewer problems with fatigue, this indicates that fewer problems 
with fatigue were associated with fewer problems on the Strengths and 
Difficulties Questionnaire.  Total Difficulties score on SDQ was similarly 
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related to the same fatigue scales. Conduct significantly correlated to mental 
fatigue of the fatigue subscales. For child scores (Table 12), Emotional 
Symptoms were negatively correlated with general fatigue (r(14) = -.80, p < 
.001), indicating higher levels of emotional problems were associated with 
high fatigue levels. Conduct problems were negatively correlated with 
mental fatigue scores (r(14) = -0.591, p = .016), which parallels the 
responses from parents on these two variables. Related to the third 
research question there was some evidence that children’s fatigue was 
related to their emotional and behavioural difficulties.   
 
Associations between variables of executive functioning and other variables 
are shown in Table 14. Emotional symptoms were correlated with four 
BRIEF subscales (Shifting, Emotional Control, Working Memory and 
Planning), as well as all three composite scores. Conduct Problems and 
Total Difficulties correlated with seven of the BRIEF subscales. These two 
SDQ subscale scores and Total Difficulties score correlated with all 
composite scores (Behaviour Regulation, Meta-cognition and Global 
Executive), which partially answered the third research question, in that 
emotional and behavioural functioning was associated with executive 
functioning.  
 
Fatigue subscales correlated with between four (for general fatigue) and 
seven subscales (for mental fatigue) of the BRIEF (Table 14).   Related to 
the third research question, there was evidence that executive functioning 
difficulties correlated with fatigue. This indicates that higher levels of fatigue 
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were associated with greater difficulties in executive functioning. 
Additionally, the association between Emotional Problems (SDQ) and 
Global Executive Composite (BRIEF) (r(29) = .46, p = .009), was no longer 
significant after controlling for fatigue (r(28) = 0.26, p = .16), using partial 
correlation.
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Table 11: Bi-variate correlations (Pearson’s r) between variables for parents’ response
  Measure 1 2 3 4 5 6 7 8 9 10  
1 Platelet count a -           
2 Bleeding severity -.41*  -          
3 SDQ- Emotion  .04 -.04  -         
4 SDQ- Conduct  .09  -.32 .22  -        
5 SDQ- Total Difficulties  .14  -.30  .64** .78**  -       
6 Quality of life KIT score b  .12  -.41*  -.40*  -.33 -.39*  -      
7 Fatigue total  -.24  .07  -.44**  -.29 -.52**  .33 -     
8 General fatigue   -.18  -.05  -.23  -.14  -.27  .31 .87**  -    
9 Sleep fatigue  -.27 .027  -.39*  -.09  -.36*  .31  .87** .76** -   
10 Mental fatigue -.19   .17  -.48**  -.45**  -.66**  .27  .85**  .56**  .55** -  
 Note.  n values varied between 30-35 depending missing data. SDQ = Strengths and Difficulties Questionnaire; KIT= Kids ITP 
Tools. Higher fatigue scores indicate lower problems with fatigue; negative correlations indicate lower fatigue problems correlate 
with low problems in other domains. 
a Transformed score used for platelet count. b Proxy report 
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
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Table 12: Bi-variate correlations (Pearson’s r) between variables for children’s responses, aged over 11 years  
 
 Measure 
Platelet 
Count a 
Bleeding 
Severity  KIT  
Total 
Fatigue  
General 
Fatigue  
Sleep 
Fatigue  
Mental 
Fatigue 
SDQ -  Emotion   .35 -.34 -.67** -.59* -.80** -.26 -.39 
SDQ - Conduct    .35 -.64** -.10 -.56* -.44 -.27 -.67** 
SDQ - Total 
Problems 
  
.43 -.64** -0.36 -.77** -.65** -.43 -.84** 
 
Note. n varied between 16 and 17, due to missing responses. SDQ = Strengths and Difficulties Questionnaire. KIT= Kids 
ITP Tools (quality of life measure). Higher fatigue scores indicate lower problems with fatigue; negative correlations 
indicate that lower SDQ problems correlate with lower fatigue problems.  
 a Transformed score used for platelet count. 
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
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Table 13: Bi-variate correlations (Pearson’s r) between variables for children’s responses, aged over 7 years   
 
 Measure  Platelet Count a  Bleeding severity  
KIT 
score 
      
 KIT score   .04 .01 - 
 Fatigue total   -.14 .23 .69** 
 General fatigue   -.17 .21 .80** 
 Sleep fatigue   -0.19 .15 .36 
 Mental fatigue   -.01 .24 .54** 
 
Note. KIT= Kids ITP Tools (Quality of life score). n varied between 33 and 34 for correlations, due to missing data. For 
correlations involving Quality of life (KIT) score, n = 24. Higher fatigue scores indicate lower problems with fatigue 
a Transformed score used for platelet count. 
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
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Table 14: Bi-variate correlations (Pearson’s r) between executive functioning (BRIEF measures) and other study variables 
 Measure 
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Inhibit  
.05 -.18 .35 .67** .75** -.21 -.55** -.38* -.37* -.68** 
Shift  
.17 -.20 .53** .53** .70** -.22 -.67** -.56** -.59** -.65** 
Emotional control  
.26 -.23 .47** .66** .64** -.40* -.50** -.39* -.42* -.51** 
Initiate  
.16 -.43* .35 .65** .74** -.14 -.47** -.29 -.43* -.50** 
Working Memory   
.20 -.16 .42* .62** .74** -.18 -.71** -.53** -.45* -.86** 
Planning   
.15 -.34 .39* .57** .67** .08 -.51** -.35 -.38* -.60** 
Organisation of Materials  
-.24 -.01 .22 .35 .32 -.03 -.23 -.08 -.13 -.35 
Monitor   
.19 -.34 .27 .56** .63** -.01 -.37* -.13 -.34 -.49** 
Behaviour Regulation   
.19 -.25 .50** .75** .81** -.34 -.62** -.46* -.51** -.68** 
Meta- cognition   
.12 -.31 .40* .67** .76** -.09 -.53** -.31 -.44* -.63** 
Global Executive Composite   
.15 -.29 .46** .73** .81** -.19 -.59** -.38* -.47** -.68** 
Note. BRIEF= Behaviour Rating Inventory of Executive Function; SDQ= Strengths and Difficulties Questionnaire. n varied between 30 
and 31 due to missing data. Higher BRIEF scores indicate greater problems. High fatigue scores indicate lower problems with fatigue.  
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed).
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3.6 Quality of life  
The mean score of self reported quality of life for children was 79.38 (SD = 
14.55). This score ranged between 39.4 and 95.2. The mean parent proxy 
ratings of child’s quality of life was 78.19 (SD = 14.45) and ranged between 
51.9 and 99.0. 
 
In exploratory analysis, variables associated with quality of life were 
examined. From the bivariate correlations (Tables 11-13) we can see that 
several variables were associated with quality of life. For parents’ ratings 
(Tables 11 & 14) this included Total Difficulties with emotional/behavioural 
functioning (SDQ), Emotional Symptoms (SDQ), and Emotional control 
(BRIEF). For child ratings, variables associated with quality of life included 
Emotional Symptoms (SDQ), and general, mental and total fatigue scores 
(Tables 12 & 13).  
 
3.7 Appraisal  
3.7.1 Associations between appraisal items (Table 15).  
In addition to the research question concerning appraisal, the characteristics 
of appraisal as related between parent and child were examined. Parent and 
child ratings of severity of illness correlated with each other, but were 
significantly different from each other (t(30) = 2.972, p = .006), with children 
rating their condition as less severe than their parents. Both parents and 
children’s rating of severity of condition correlated with their ratings of the 
amount their life was affected. Parent’s rated their own life as more affected 
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if their child’s life was more affected. Parent’s perceived ability to cope was 
associated with their report of their child’s ability to cope. For parents, 
appraised severity was significantly negatively correlated with their appraisal 
of their own ability to cope. This was not the case for children; severity rating 
did not correlate with coping ability. Child’s rating of the severity of their 
illness was positively correlated with the amount their life had been affected. 
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Table 15: Association between appraisal items  
  Parent ratings Child ratings 
Measure 
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Parent’s ratings          
Severity   -        
Child’s life 
affected 
 .70
**
 -       
n 34        
Own life affected 
 .46
**
 .61
**
 -      
n 34 34       
Own coping  -.56
**
 -.48
**
 -.45
**
 -     
n 34 34 34      
Child’s ability to 
cope 
 -.28 -.24 -.12 .53
**
 -    
n 34 34 34 34     
Child’s ratings          
Child’s severity  .37
*
 .22 .084 -.076 .002 -   
n 31 31 31 31 31    
Life affected 
 .44
*
 .34 .15 -.24 -.046 .76
**
 -  
n 23 23 23 23 23 25   
Ability to cope 
 -.29 -.54
**
 -.22 .28 .17 -.22 -.19 - 
n 23 23 23 23 23 25 25  
*. Correlation is significant at the 0.05 level (2-tailed) 
**. Correlation is significant at the 0.01 level (2-tailed). 
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3.7.2 Associations of appraisal with adjustment.  
Each appraisal aspect (severity, affected life, and coping ability) is reported 
in turn. To answer the fourth research question, concerning appraisal and 
adjustment, each appraisal item was correlated with each adjustment item 
(fatigue, executive functioning, emotional and behavioural functioning, and 
quality of life). Some additional analyses were carried out between the three 
sources of severity rating, as each one was thought to contribute meaningful 
data and their association would assist in interpreting the other results.  
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Table 16: Bivariate correlations (Pearson’s r) of parent appraisal ratings with other variables  
  
Platelet 
count 
Bleed 
severity  
SDQ- 
Emotion 
SDQ- 
Conduct 
SDQ- 
Total 
Difficulties  
KIT 
summary 
score 
Fatigue 
Total  
General 
Fatigue  
Sleep 
Fatigue  
Mental 
Fatigue  
Severity  
.13 .30 -.01 .11 .13 -.31 -.33 -.40* -.26 -.20 
Child’s life 
affected 
 
.11 .24 .16 .39* .44** -.47** -.42* -.36* -.28 -.41* 
Own life 
affected 
 
.14 .018 .11 .42* .32 -.30 -.41* -.32 -.22 -.45** 
Own ability 
to cope  
 
-.01 -.19 -.24 -.26 -.23 .53** .12 .16 .05 .09 
Child’s 
ability to 
cope 
 
-.01 .12 -.17 -.24 -.20 .45** .02 -.01 -.02 .06 
Note. N values varied between 32-34, due to missing data. SDQ = Strengths and Difficulties Questionnaire. KIT = Kid’s ITP 
Tools (quality of life scale)  
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
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Table 17: Bivariate correlations (Pearson’s r) of child appraisal ratings with other variables  
 Measure  
Platelet 
count 
Bleeding 
severity  
SDQ- 
Emotion 
SDQ- 
Conduct 
SDQ- Total 
Difficulties  
KIT 
summary 
score 
Fatigue 
Total  
General 
Fatigue  
Sleep 
Fatigue  
Mental 
Fatigue  
Severity  r  -.03 -.07 .43 .31 .36 -.58** -.51** -.52** -.44** -.33 
N  34 34 16 16 16 24 34 33 34 34 
Life 
affected  
r  .34 -.08 .40 .22 .31 -.44* -.63** -.49* -.59** -.50* 
N  25 25 16 16 16 24 25 25 25 25 
Ability to 
cope  
r  .31 -.41* -.31 .23 .08 .36 .20 .18 .07 .22 
N  25 25 16 16 16 24 25 25 25 25 
Note. KIT = Kid’s ITP Tools (Quality of life scale)  
*. Correlation is significant at the 0.05 level (2-tailed). **. Correlation is significant at the 0.01 level (2-tailed). 
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Severity.  
Clinicians mean rating of severity of illness was 1.28, compared with 
2.82 as rated by parents and 1.94 for child ratings. There was a significant 
correlation between clinician rating and both parent (r(32) = 0.622, p < .001) 
and child ratings (r(32) = 0.658 , p < .001). This indicates that high ratings 
from clinicians corresponded with high ratings from the other raters. However, 
clinicians’ ratings were significantly lower than parent ratings (t(33) = -8.712, 
p < .001) and child ratings (t(33) = -2.878, p = .007. Neither platelet count nor 
bleeding severity correlated with any of the three subjective ratings of 
severity.   
 
Parent’s rating of severity correlated with one fatigue subscale, general 
fatigue, indicating the more severe the condition was rated, the worse the 
general fatigue levels (Table 16). Child’s rating of the severity of their illness, 
negatively correlated with their general, sleep and total fatigue scores, 
indicating those that reported a more severe condition also reported more 
problems with fatigue (Table 17). For children, their rating of their quality of 
life was negatively correlated with the perceived severity of their illness, with a 
more severe illness equating to a poorer quality of life.  
 
Life affected.  
As seen in Table 16, parents rated their own life as more affected if 
their child had greater conduct problems, higher total and mental fatigue and 
greater problems with emotional control (r(28) = .40, p = 0.03), and working 
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memory (r(28) = .45, p = 0.01). Parents’ rating of the amount their child’s life 
is affected correlated with the same measures and, in addition, general 
fatigue. For parents, quality of life for their children was associated with the 
amount child’s life was affected. Child’s rating of the amount their life was 
affected by their condition correlated with Emotional Symptoms (SDQ), total 
fatigue and all three fatigue subscales (Table 16). Child–rated quality of life 
was also associated with the amount their life was affected. 
 
Ability to cope.  
Parents rated quality of life for their child was better when they 
perceived higher coping ability in themselves and in their child (Table 15). 
Children with lower bleeding severities, reported being more able to cope 
(Table 16).  
 
In summary, as all appraisal variables were associated with at least one 
adjustment variable, related to the fourth research question. 
 
3.8 Qualitative comments  
Additional comments in the questionnaire packs gave support to the research 
questions examined above about the psychological adjustment profile of 
children with ITP. Several issues were presented in the qualitative comments 
from the KIT and the VAS measures. Parents reported that they were 
bothered by the uncertainty around the illness and its prognosis, its risk 
management (including restricting activities), and its visual appearance. 
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Parents commented that they thought the issues that affected their children 
were the blood tests, the anxiety around the condition, specific physical 
complaints, and isolation from friends. Some comments from parents 
commented on how the situation at present was more positive than it had 
been previously, which reflects the changeable nature of the condition. 
Themes from child comments concerned being bothered by restricted 
activities, anxiety around the time-course and prognosis of the illness, and 
blood tests.  
 
4. Discussion 
This study aimed to address gaps in the literature regarding the psychological 
profile of immune thrombocytopenia (ITP) in children. There has been recent 
interest in the quality of life for children with this condition (E.g., Klaassen et 
al., 2007) but knowledge about other adjustment variables remains scarce, 
despite requests for their investigation. There have been a limited number of 
studies in adults with ITP but as the condition presents quite differently in 
children and adults (Schulze & Gaedicke, 2011), it is important to investigate 
these populations separately. This study examined emotional-behavioural 
functioning, fatigue and executive functioning as adjustment variables and 
investigated the relationships between these variables with quality of life and 
factors associated with the condition (platelet count and bleeding severity).  
The first main research question concerned the adjustment profile for children 
with ITP compared with a ‘healthy’ sample of children, without the condition. 
As previous studies regarding associations between clinical factors and 
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adjustment have been mixed (Wallander & Varni, 1998) but considering 
research with the field of ITP (Newton et al., 2011), one of the research 
questions addressed whether this association would be observed in children 
with ITP. Another research question concerned the relationship between 
adjustment variables, similar to known links between mood, fatigue and 
thinking skills (Fleming et al., 2004; Goretti et al., 2012; Swain, 2000). Finally, 
this study introduced the construct of appraisal and investigated its influence 
on adjustment outcome. In relation to background literature for other 
paediatric conditions the final research question concerned whether, within 
the sample, more positive appraisal would be related to better adjustment. 
Each of these research questions are discussed in turn, including dissection 
of each adjustment variable, with implications of the findings, then the study is 
evaluated in terms of its strengths and weaknesses and conclusions are 
presented.  
 
4.1 Main findings  
4.1.1 Emotional-behavioural functioning.  
The first adjustment variable examined was emotional and behavioural 
functioning. Most children were rated by the parents to have no significant 
problems with emotional and behavioural functioning. Additionally, children 
did not rate their functioning as worse compared with children without ITP. 
However, parents rated their children with ITP as having significantly higher 
rates of emotional symptoms compared to the general child population.  This 
is consistent with previous research literature that has shown some increased 
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risk for psychological problems for children with chronic health conditions 
(Barlow & Ellard, 2005) and findings of higher rates of emotional symptoms 
(anxiety and depression) in children with other blood disorders (Yang et al., 
1994). Anxiety and distress were additionally mentioned by parents and 
children in their qualitative comments in the current study. However, as 
children and parents differed in their ratings, caution should be applied when 
making conclusions about the level of difficulties for this group. It cannot be 
ruled out that parental well-being, not measured in this study, was influencing 
their judgements.  
It is possible that the presence of ITP affects mood in the way that the 
presence of any chronic health condition might. For example, the burden of 
hospital appointments and anxiety around the condition might be expected to 
be similar to other conditions. However, issues specific to ITP, such as 
restricted activity, potential for increased anxiety given the uncertainty about 
the condition and the visibility of condition may additionally affect mood. 
Indeed some of these issues were highlighted by comments from parents and 
children (see below).  Previous research in children with chronic health 
conditions found that activity restriction mediates the relationship between 
illness characteristics and depression (Walters & Williamson, 1999). There 
may also be a biological mechanism underlying mood difficulties, such as the 
role of platelets as discussed below.  
Parental ratings for behaviour (or conduct) problems were higher for children 
with ITP compared with the normal population, and this difference 
approached significance (p= 0.051). Although some literature shows that 
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behavioural problems are more common in children with health conditions 
(Pinquart & Shen, 2011), including blood disorders such as haemophilia 
(Trzepacz et al., 2003) and conditions that are considered medically benign 
(Connolly et al., 2006), most literature also concludes that the majority of 
children are not at increased risk of emotional or behavioural problems (e.g. 
Trzepacz et al., 2003).  
4.1.2 Fatigue.  
In answer to the research question, both children and their parents 
rated child fatigue as significantly worse compared with a sample of children 
without ITP. This supports results from surveys (Sarpatwari et al., 2010), 
focus groups (Barnard et al., 2003) and anecdotal reports from haematology 
professionals that fatigue is a significant symptom for children with ITP. 
However, there was considerable spread of fatigue scores, indicating that 
many children may have had little to no problem with fatigue. There is also no 
cut-off score for the measure used, to determine the severity of the scores.  
 
This is the first study to explore fatigue using a standardised quantitative 
fatigue measure for this group. Fatigue scores were also compared with those 
for children with sickle cell disease (SCD), but this produced mixed findings. 
Parents’ ratings of child fatigue levels were not significantly different with the 
SCD comparison group, whereas children reported fewer problems with 
fatigue compared to children with sickle cell disease. As fatigue is a 
subjective construct child ratings may be considered to be the ‘best’ ratings, 
although these are subject to self-report biases. In addition, the sample of 
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children with sickle cell used for comparison used a slightly larger age range, 
including older children up to the age of 18. As our current study found that 
older children had greater problems with fatigue this may have been an 
influence in the comparison sample.  
 
Fatigue can be affected by steroid treatment (Provan et al., 2010), but as no 
children in this sample were receiving steroid treatment at the time of the 
study, this indicates other mechanisms are operating. Possible biological 
mechanisms for fatigue in ITP include general psychological stress, possibly 
mediated through Corticotrophin-releasing hormone (CRH) (Swain, 2000), 
through serotonin or other biological effects affected by reduced platelet 
count/abnormal auto-immune response (Hill & Newland, 2015), due to 
elevated levels of inflammatory cytokines (Kistanguri & McCrae, 2013; Swain, 
2000) or through oxidative stress processes (Kamhieh-Milz & Salama, 2014). 
It is also possible that fatigue was related to other co-morbid health conditions 
(Newton et al., 2011), to low mood (Swain, 2000), reduced activity/exercise 
(Lewis & Wessley, 1992), or low self-efficacy (Riemsma et al., 1998) as found 
in other studies.  
 
Fatigue may be related to toxicity of treatments (Zehnder et al., 2010). 
Despite none of the children in this study being currently on steroid treatment, 
there was a difference in the levels for those on treatment compared with 
those who were not. This may indicate side effects of these treatments, or 
may reflect the severity of the condition that warranted treatment 
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commencement. In treatment studies for adults with ITP, fatigue has been 
reported as an adverse side effect for some treatments (Kuter et al, 2013) 
and longitudinal treatment studies have failed to improve levels of fatigue, 
despite improvements in other quality of life domains (Kuter et al., 2010). 
Increase in fatigue may have knock-on effects such as problems with 
academic functioning, engagement with social and leisure activities (McCabe, 
2009) and it is therefore an important variable to investigate. 
 
4.1.3 Executive function.  
Executive functioning was used as another measure of adjustment and 
the research questions concerned whether this would be worse for children 
with ITP compared with a healthy population. It has been recognised that the 
cognitive profile of children with ITP has been under-researched and 
recommendations have been made that this should be an area of research 
focus (Cooper, 2014). This study is the first to investigate executive function 
in children with ITP, and contributes to understanding the cognitive profile for 
this group.  
 
Overall executive functioning (as measured by the Global Executive 
Composite and Behaviour Regulation scales of the BRIEF) and Emotional 
Control was significantly worse compared with a normative group. Although, 
almost 20% of this sample of children with ITP had a high level of problems 
with overall executive functioning and in the normal population only 6.6% 
would be expected to have scores within this range, this still represents that 
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the majority of children in this study (80%) had no significant difficulties with 
executive function. These results remain tentative given the sample size and 
other limitations of the study. It should be stated again that in this study 
executive functioning of the children was ascertained through parent report, 
which may provide different results to formal cognitive testing. If a finding of 
increased prevalence executive functioning difficulties for children with ITP 
was supported through further research, it remains likely that the majority of 
children would experience no difficulty. There were no significant differences 
on the BRIEF between this sample of children with ITP and a comparison 
study of children with sickle cell disease. However, these results should be 
viewed with caution given the small sample sizes in the current study and the 
comparison sample.  
 
It is unclear whether any biological mechanism contributes to executive 
functioning difficulties. These could be explored in future research if findings 
with regard to executive functioning difficulties were verified. An alternative 
explanation would be that executive functions, such as ability to organise 
oneself may be affected by missing school which may provide a context for 
developing these skills. As none of the children were currently on steroid 
treatment, the cognitive effects reported are mostly likely to be due to other 
factors, although previous steroid use was not investigated in this study. 
Finally, executive function changes may be related to the other adjustment 
variables, as discussed below.  
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4.1.4 Quality of life.  
Quality of life could not be used as an adjustment variable in the same 
way to compare to other child populations as it is an ITP-specific measure. 
However, its inclusion in the current study provided information about how 
other factors related to quality of life within this condition, as discussed below. 
Average quality of life (QoL) scores were comparable to other studies of 
children with ITP using the same measure (Flores et al., 2013; Klaassen et 
al., 2013). However, there was considerable variation in QoL scores. For 
example, child ratings varied from as low as 39.4 to 95.2/100. This 
emphasises this variability in quality of life across this sample, and parallels 
the patterns observed across a wider population of children with ITP.  
 
4.2 Association between adjustment variables  
This study found a significant relationship between adjustment 
variables of executive function, fatigue and mood. The association between 
mood and executive function is in line with research in adults with depression 
(Chepenik et al., 2007) and for anxious-depressed boys (Emerson et al., 
2004). The association between fatigue and mood in this study was in line 
with findings across paediatric literatures (as reviewed by Swain, 2000). 
Fatigue is an under-researched area in children (McCabe, 2009). In relation 
to this, literature relating to fatigue and executive functioning is scarce. 
However, the association between these two variables is in keeping with a 
recent study for children with MS, who had poorer performance on executive 
function tests if reported to be cognitively fatigued (Goretti et al., 2012). Very 
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few studies have examined these three variables in the same study and in 
this way this study benefits from their simultaneous examination.  
 
Children’s quality of life scores were significantly related to child emotional 
symptoms, for both parent and child ratings. Other studies have found an 
association between emotional symptom scores and quality of life (Tracy, 
Dechant, Sperling, Cho, & Glosser, 2007) and a possible role for emotions 
moderating the effect of functioning ability, or disability status, on quality of life 
(Janssens et al., 2003).  
 
This association could be due to the inclusion of mood items in the QoL scale 
and some researchers have stated that mental health factors should not 
dominate quality of life measures (Tracey et al., 2007). The quality of life 
measure that was used in this study has only three items which directly 
address mood (i.e., ‘I felt cranky’, ‘I felt upset’, ‘I felt anxious’) but also 
additional items assessing somatic symptoms and some items that asked 
about specific worries (e.g., ‘I worried about my platelet count’). Other items 
asked about children being ‘bothered’ by events or aspects of the condition 
(e.g., ‘I was bothered that I could not do anything to get better’) and it is not 
clear how much this phrasing overlaps with constructs of mental health.  
 
For parent ratings, scores for emotional-behavioural functioning (Total 
Difficulties on the SDQ), and Emotional Control (BRIEF) were related to 
child’s quality of life. This may indicate that quality of life ratings as made by 
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parents are based mostly on observable symptoms. From the child’s 
perspective, general, mental and total fatigue scores were related to quality of 
life. Only one item of the KIT directly asks about tiredness so this is likely to 
be a genuine association rather than just construct overlap. This finding 
replicates findings reviewed for fatigue and quality of life in children with 
chronic health conditions (Eddy & Cruz, 2007).  
 
4.3 Association of clinical measures with adjustment 
Informed by the risk and resistance model, one of the research questions 
addressed whether clinical features of ITP, including platelet count and 
bleeding severity would be related to adjustment. There was no association 
between clinical factors and poorer emotion-behavioural functioning, fatigue 
or executive functioning (apart from one subscale).  
 
Platelets have a role in transportation of serotonin (Berger et al., 2009), and 
therefore increased destruction/reduced production of platelets may affect 
these neurotransmitter levels, which would affect mood regulation.  Although 
there was no correlation between platelet count and emotional symptoms in 
this study, all children had had altered platelet counts in the last six months. 
Once below 150 x 103 platelets per micro litre (mcL), smaller variations may 
not make a difference. It would be interesting to know whether comparing 
platelet counts in the normal range compared with the current sample would 
find an association.   
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This study found that higher bleeding severity was related to fewer 
behavioural problems. At first this result seems perplexing. It is not possible 
from this study to explain this finding but it may be that caring behaviours 
from parents increase with more observable bleeding and this in turn may 
reduce behavioural problems. Alternatively, children who are less ill (low 
bleeding severity) may feel more able to ‘act out’ against unwanted 
restrictions on their activity and attending hospital appointments. Also, at 
higher bleeding severities, treatment may be more readily considered and 
delivered. Although the relationship between bleeding and treatment was not 
examined in this study, this may provide conflicting results as treatment may 
be initiated for those with high bleeding severity but being on treatment may 
keep bleeding severity down. Also this would not account for previous 
treatments, and their duration and their potential effects over time on conduct, 
even if discontinued.  
In answer to the third research question, the current study found no 
relationship between either platelet count or bleeding severity with fatigue and 
only one executive function subscale was associated with bleeding severity. 
This is in contrast to the results for fatigue in adults reported by Newton et al. 
(2011). However, there are some studies in adults which had similar findings 
(Sarpatwari et al., 2010; Zhou et al., 2007). In other blood disorders, deficits 
in cognitive problems are related to some measures of condition severity, 
such as intracranial haemorrhage and anaemia (Hijmans et al., 2011; Morales 
et al., 2013), but results from the current show no association with condition 
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severity as measured by platelet count and bleeding severity on the whole 
with executive functioning.  
 
Finally, neither platelet count nor bleeding severity was associated with 
quality of life. This replicated the finding of Neunert et al., (2009) who also 
found no relationship between these measures. This indicates that other 
factors associated with the condition, beyond clinical severity may be 
impacting on children’s lives.  
 
4.4 Appraisal  
The final research question concerned the role of appraisal and adjustment. 
Appraisal has been shown to be related to outcome in chronic health 
conditions (e.g., Guion & Mrug, 2012). This is the first study to incorporate a 
measure of appraisal in examining adjustment outcome in ITP. The three 
areas that were addressed in the bespoke visual analogue appraisal measure 
(VAS) are discussed below. Results should be viewed with caution 
considering the novelty of the measure. 
 
 Severity.  
Parents, children and clinicians differed on their severity rating of ITP, 
with clinicians rating it as the least severe, then children, and parents giving it 
the highest severity rating. Clinicians would have based their ratings on blood 
counts and bleeding symptoms, infrequent presentations of the child to clinic 
and reports from families. They may not have insight to the range of 
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psychosocial factors that may influence perceived severity for parents and 
families. Research on subjective severity ratings for children with sickle cell 
disease found that clinicians were more likely to rate the condition as less 
severe than parents and children when objective clinical measures indicated 
a less severe disease (Connelly, Wagner, Brown, Rittle, & Cloues, 2005). 
Alternatively, families may have misunderstood the severity of the condition. 
This has important implications for clinical dialogue between clinicians and 
families to ensure that clinicians are aware of all symptoms and parental or 
child concerns and wherever appropriate, to try to reassure parents and 
children when the condition is in fact relatively mild. This finding parallels 
reports from the adult ITP literature, where discrepancies in perceptions about 
medication side effects between clinicians and patients were found (Guidry et 
al., 2009).  
 
The finding that children rated their condition as less severe than their parents 
parallels similar findings for children with sickle cell disease (Connelly et al., 
2005). Children, particularly young children, may not know extensive details 
about their condition, which may influence their ratings. Alternatively, parents 
may rate the condition higher in severity if they are not adjusting well to their 
child’s condition (Connelly, et al. 2005), which was not examined in this 
current study. These results emphasise the utility of multiple reports.  
   
Neither platelet count nor bleeding severity was significantly correlated with 
any of the three subjective ratings of severity and only child severity ratings, 
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not condition factors, were related to child’s quality of life. These findings 
support the finding that perceived severity of a health condition is a subjective 
measure, which is not necessarily related to objective clinical measures of 
severity, as has also been reported for sickle cell disease (Barakat et al., 
2006)  
 
Ability to cope.  
Children with lower levels of bleeding severity reported being more 
able to cope with their condition. One possible explanation for this is that the 
bleeding severity scale incorporates presence of bruising and this result 
suggests that observable symptoms may affect coping ability. It may be if 
more severe bleeding occurs it may be observed by others which would have 
social consequences. However, it may also be individual management of 
bleeding that is hard. For instance, heavy periods were mentioned as a 
concern by children and parents.  
 
Parents perceived a better quality of life for their child when they and their 
child could cope with the condition. However, it may be that a better quality of 
life led to a perception of better coping. As this was a cross-sectional 
correlation, causality cannot be inferred. This finding has been in observed in 
other paediatric conditions. For instance, for children with cancer, perceived 
ability to enact coping strategies was related to better quality of life 
(Cunningham et al., 1991).   
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Life affected.  
As might be expected, parents rated their lives as more affected if their 
children’s lives were more affected. Parents not only have to deal with the 
psychological consequences of a condition on children but also the 
practicalities of monitoring and treatment, such as attending hospital 
appointments. Parents reported that their own life was affected if children 
displayed particular adjustment difficulties, including behaviour, working 
memory and fatigue difficulties. This is related to literature that shows a 
similar relationship between reported impact and greater behavioural and 
cognitive problems, in a study of children with epilepsy (Camfield et al., 2001). 
Parental well-being was not specifically examined in this study but should be 
considered in paediatric settings. 
 
Some, but not all, of the appraisal ratings were related to quality of life. In 
addition to associations discussed above, appraisal scores also related to 
other adjustment variables including fatigue, conduct (parent ratings), and 
emotional symptoms (child ratings). In each case, more positive appraisal 
ratings, including higher perceived coping ability, and lower rating of life being 
affected by the condition, was associated with better outcome on these 
adjustment variables. Therefore, there was some evidence that a more 
positive appraisal would be associated with better adjustment. The 
relationship between appraisal and adjustment outcomes is likely to be a 
complex one. For instance, it is not clear whether children and their parents 
were predisposed to particular appraisals, or whether positive or negative 
121 
outcomes of the condition changed their view on their appraisal of the illness. 
As items from the VAS appraisal measure correlated with more of the 
adjustment outcomes than platelet count, it may be important to examine 
appraisal, and stress processing more broadly, in future studies.  
 
4.5 Qualitative comments  
Although not a focus of this study, the written comments provided by children 
and families provided richness to the data and supported quantitative 
findings. Several comments were made by parents and children about 
restriction on physical activities. The frequency of comments about activity 
restriction was surprising given that this is not usually advised by clinicians 
except in the first 12 months of the condition when platelet count is 
particularly low (Blanchette & Bolton–Maggs, 2010). Given the rarity of the 
condition, general practitioners or paediatricians may not be as familiar with 
the guidelines for lifestyle management and therefore unnecessarily suggest 
a restriction in physical activities. As many of the children had been seen for a 
long time at the specialist centres where they were approached for the study, 
this is unlikely to be the case in the current cohort, although cannot be ruled 
out as having occurred in the past. It may also be that parents and children 
choose to take a ‘better safe than sorry’ approach and limit activity despite 
clinical recommendations. Children also commented that they felt isolated 
from friends, and it is not clear whether this was related to activity restriction 
(physically isolated) or due to being perceived as different (psychologically 
isolated).  
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Both parents and children were bothered by the uncertainty around the 
illness. Unknown cause and aetiology, multiple treatment options, the ‘watch 
and wait’ approach and unknown prognosis/chance for spontaneous 
remission are specific to ITP and likely contribute to anxiety. This is related to 
research literature for other conditions that suggest that increased uncertainty 
is associated with poor psychological outcomes for children (Hoff et al., 
2002).   
 
Finally, blood tests were an issue for children despite anaesthetic creams 
being used and despite children’s familiarity with the procedure. Although a 
necessary part of ITP monitoring, the effect of this procedure on children 
should not be underestimated and additional steps to alleviate anxiety should 
be considered, which might include targeted psychological intervention 
around needle phobia and procedural anxiety.  
 
Finally, comments were also made about visible signs of the condition, mainly 
bruises, although it is not clear what bothered them about these. For instance, 
whether they were worried about appearance or whether these visible signs 
acted as a reminder about other potential ongoing effects of the illness.  In 
literature regarding children with chronic conditions, body image concerns are 
known to be related to measures of well-being (Wolman, Resnick, Harris, & 
Blum, 1994). However, this may also depend on the appraisal and meaning 
given to the visibility of the symptoms.  
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4.6 Theoretical implications  
This study advances knowledge in areas where there were significant gaps 
about the psychological profile of children with ITP. It adds to current 
understanding about fatigue, emotional and behavioural difficulties and 
executive function difficulties, using standardised measures, which have not 
previously been used for children with ITP. Theoretical models have not been 
used to date to help understand adjustment in ITP. The design of this study 
meant it was not possible to test particular elements of the risk and resistance 
model (Wallander & Varni, 1992). Nevertheless, the model provides a useful 
framework for considering how aspects of the condition fit together. Figure 5 
shows a suggested adaptation to the model, including variables investigated 
in this study as well as gaps remaining, for further research.  To reiterate, not 
all links shown in the figure were explored in the current study and the results, 
particularly the inter-relationships between variables highlight the complexity 
and limitations of the model, as discussed further below.  
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Figure 5: Adapted Risk and Resistance model for ITP  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Note. Dashed lines and italicised variables indicate pathways suggested in the 
original risk and resistance model (Wallander and Varni (1992), but not explored in 
the current study. Solid lines indicate associations explored in the current study.  
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The primary aim of this study was to understand the adjustment profile for 
children with ITP. Increased rates of adjustment difficulties, as measured by 
total emotional and behavioural problems, emotional symptoms specifically, 
and fatigue problems, were found in this sample and these have been added 
to the diagram (Box A). Again, it is important to emphasise that although there 
were higher proportions of children experiencing difficulties in these domains, 
a large proportion of children were reported to experience no significant 
difficulties. This study found evidence that executive functioning may be 
affected in children with ITP. It is not clear from this study whether these 
difficulties should be included under the model as a characteristic of ITP or as 
an outcome, or both, and it is likely that this would not apply to all children 
with the condition. It may be that broad cognitive changes occur that relate to 
changes in brain blood flow or other biological mechanisms whilst more 
specific effects on cognition (e.g., executive functioning) are exacerbated by 
difficulties in fatigue and mood.  
 
The risk and resistance model has been criticised for failing to define 
relationships between variables (Holmbeck, 1997). Related to this, the 
original model does not discuss the potential interrelationships between 
adjustment variables. This current study found that there were significant 
associations between adjustment variables. Lines have been added to 
indicate these (Figure 5, Box A). These indicate associations between 
executive function, fatigue and emotional functioning, conduct problems as 
related to fatigue and executive functioning and quality of life related to 
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fatigue and emotional functioning. Conduct and executive functioning are not 
linked in the diagram to quality of life, in line with current findings. Two-way 
arrows have been used in the diagram as this study did not provide 
information as to the direction of these relationships. Further research is 
required to test these relationships.  
 
It is difficult to encompass the role of condition factors in to the model, given 
the current findings. Platelet count did not seem to be directly related to 
adjustment variables, although this has been kept in the model as it is not 
clear whether this might affect other variables that were not studied. It is 
possible that platelet count may not be a good clinical marker and general 
representation of the illness. The relationship of bleeding severity to 
adjustment is indicated by Line B, but this does not represent a link to all 
variables. It represents association with one subscale of BRIEF and child 
quality of life as rated by parents. It also related to conduct as rated by 
children although in the unexpected direction of higher bleeding related to 
fewer behaviour problems, as discussed above.  Again, it may be that 
bleeding severity influences other variables through indirect pathways. 
Results from this study support a pathway linking bleeding severity to child’s 
appraisal (Line C), as children perceived they could cope better when they 
had lower bleeding severities. This direct link is not suggested in the original 
model (Wallander & Varni, 1992).  
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The original model suggests that condition factors have not only direct effects 
on adjustment, but also mediated effects through stress (Pathway D). Generic 
daily stress, condition related stressors and significant life events have been 
shown to effect a person’s adjustment (Casey et al., 2000; Coker et al., 2011; 
Perrin et al., 1996) and mediate the relationship between physical symptoms 
and adjustment (Casey et al., 2000). Due to mixed results for direct effects of 
condition factors on adjustment, it seems important to investigate indirect 
routes that these variables could be operating in individuals with ITP.  
 
Side effects of treatment and visibility of condition are suggested in the 
original model and although not investigated in the current study were 
important to add. ‘Side effects’ were added as toxicity of treatments has been 
a highlighted issue for children with ITP (Zehnder et al., 2010). ‘Visibility’ has 
also been added as its role is supported by Varni and Setoguchi’s (1991) 
research that shows that higher perceived physical appearance was related 
to better outcome in terms of anxiety and depression scores. However, the 
important term here is ‘perceived’ and it has been suggested that subjective 
rather than objective appearance and the appraisal on this is what affects 
outcome (Varni & Setoguchi, 1996). As bleeding severity as used here 
considered observable signs of bleeding, this measure may be related to 
visibility and warrants further study.   
 
It is difficult to draw clear conclusions about the association between gender 
and age with outcome as there were mixed results in the study and only 
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examined in brief. Largely, age and gender were not related to adjustment 
variables. The exceptions to this were for age and emotional problems and for 
age and gender with executive functioning. There was also a trend 
association between age and fatigue, with older children reporting greater 
difficulties. Therefore this has been tentatively added as a line to the model 
(line E), to represent that an association may exist for certain variables. The 
original model proposes that personal characteristics, including age and 
gender would influence child appraisals (Wallander & Varni, 1992) (Line F). 
For instance, some studies have shown that girls may perceive stressors as 
more severe (Walker, 2007). The influence of age and gender on appraisal 
was not examined in this study.  
 
A direct line (line G) has been added to the model to show the link between 
child appraisal and adjustment. This represents two of the appraisal domains 
being related to quality of life and fatigue and one appraisal domain related to 
emotional symptoms. Children’s ratings of their ability to cope were not 
related to adjustment outcomes and this item may not have been accessing 
the same overall construct as indicated by internal consistency analysis of the 
appraisal measure.  As proposed in the original model, there is a possible 
moderating effect for cognitive appraisal between other variables. This was 
not investigated in this study but would be important if investigating appraisals 
further for this population, and is represented by pathway H.  
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Although not considered directly in the original model, there is a hypothesised 
indirect association between parental appraisal and child adjustment (Hocking 
& Lochman, 2005; Wallander & Varni, 1992). Other literature has examined 
these associations. For instance, perceived impact, perceived ability to cope 
and appraised threat of a condition as rated by parents have all been shown 
to be associated with poor outcomes in children (Camfield, Breau & Camfield, 
2001; Sales, et al., 2008; Stuber et al., 1997). In the current study, there was 
association between parents’ appraisal with several adjustment domains, 
including conduct problems, emotional control, and fatigue (this is signified by 
Line I). Although it is not possible from this study to determine the direction of 
this relationship, conceptually it would make sense if parents’ lives were 
affected by adjustment problems rather than adjustment problems increased 
if parents’ lives were more affected. Generally, parent and child appraisals in 
the same domain (i.e., impact, severity, ability to cope) were not related.   
 
Although adults and children with ITP have different presentations and time 
course of the illness (Schulze & Gaedicke, 2011), similar psychological 
outcomes, such as difficulties with fatigue are reported for both groups (e.g., 
Sarpatwari et al., 2010). Research into adults with ITP has started to consider 
the theoretical links between variables (Mathias et al., 2008) but may also 
benefit from considering the model proposed above. Furthermore, it is likely 
that associations between variables investigated in this study and proposed in 
the model above would be common across disorders (Stein & Jessop, 1982) 
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and therefore this research also adds to an understanding of paediatric 
conditions as a whole.  
 
4.7 Clinical implications  
It is suggested that a range of factors should be considered in treatment 
decisions for children with ITP (Buchanan & Adix, 2001). This research 
highlights to clinicians the secondary (psychological) characteristics of ITP 
present in some children with ITP, which up until this point, were suspected 
but unverified. These may influence treatment decisions as paediatric 
healthcare provision should support the holistic presentation of the child. Also, 
beyond treatment of the ITP itself, clinicians may want to additionally screen 
for and treat psychological issues, which may result in better outcomes for 
children experiencing difficulties. Furthermore, there is some evidence to 
suggest that in haemophilia, stress may actually bring on bleeding events 
(Mattson & Gross, 1966; Perrin et al., 1996). It is unknown whether there 
exists any similar pattern for ITP, but it is plausible that similar mechanisms 
may be operating. Therefore, detecting and addressing psychological 
difficulties may even provide an indirect non-invasive treatment for bleeding 
symptoms.   
 
This study demonstrates that fatigue is a significant problem for some 
children with ITP. A clinical implication of this is that fatigue symptoms should 
be routinely asked about in ITP clinics and appropriate support provided, as 
necessary. This may include CBT interventions that have been effective in 
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reducing fatigue in other conditions (Gielissen, Verhagen, & Bleijenberg, 
2007; Knoop, Stulemeijer, de Jong, Fiselier, & Bleijenberg, 2008). As 
increasing physical activity is effective at reducing fatigue (Koornstra, Peters, 
Donofrio, van den Borne, & de Jong et al., 2014), conversation needs to take 
place between clinicians and families about the balance in risk management 
of internal bleeding from activity-related injury versus the benefits of activity, 
on an individual case basis.  
 
Recently, it has been suggested that in order to better support those with ITP 
and fatigue there needs to be a greater understanding of the treatable causes 
of fatigue, such as mood disorder (Hill & Newland, 2015). This study provides 
evidence of association between fatigue and mood problems in ITP. This 
would suggest that both direct interventions for fatigue, such as sleep 
hygiene, and interventions for mood may be effective in reducing fatigue.  
 
Although results from the current study indicate that child fatigue, at least as 
rated by parents, is worse for those on treatment, it cannot be established 
whether the fatigue is due to treatment or whether children were experiencing 
significant levels of fatigue along with other symptoms that warranted 
treatment commencement. If the former, this could influence decisions about 
whether to start treatment.  
 
As parents reported that certain adjustment characteristics of their children, 
such as fatigue, conduct and some executive domains, significantly affected 
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their own lives, parental well-being should be considered when these issues 
are highlighted in clinical settings for children with ITP. Parents and children 
may also benefit from having a better understanding of the condition, its 
mechanisms and the recommendations around activity restriction. This may 
be achieved through conversation with the clinician but also reflects that the 
clinical research in understanding ITP is still developing.  
 
4.8 Strengths and Limitations 
This study had several strengths. This was the first study to investigate 
psychological adjustment in children with ITP. Furthermore, it benefited from 
using standardised measures and multiple (self and informant) reports. It also 
enhanced the literature regarding the relationships between variables as 
these were examined simultaneously.  
 
All parents and children approached agreed to take part in the study and took 
questionnaires. Although, some questionnaires were then not returned, this 
initial response indicated that the study was in principle acceptable to 
families. Beyond this, parents were keen for this research to take place and 
often asked follow up questions whilst the study was being introduced. As 
participants were asked to report at a single time point only, this meant that 
demand on participants was low.  
 
The study benefitted from recruiting a sample that had a good spread of 
children across the age range and had an approximately equal mix of girls 
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and boys. This sample was felt to be generally representative of the wider 
child ITP population. However, it should be noted that children were seen at 
hospital sites with specialist haematology services. Whilst this would not have 
affected the age or gender characteristics, the sample may reflect more long-
standing or complex ITP presentations. There was a large heterogeneity in 
the duration of the condition. Length of diagnosis was not investigated and so 
it is unclear what influence this may have had on the psychological profile of 
children, including whether difficulties were experienced more or less for 
children who had the condition for longer.     
 
The study benefitted from using both child and parent proxy reports. Asking 
children themselves seems appropriate particularly in asking about subjective 
constructs such as fatigue. However, informant report may provide a more 
objective measure. In fact, each perspective is likely to be equally valid and 
allows a fuller understanding of the variables under investigation.  
 
Other studies of fatigue have often combined or confounded sleep and fatigue 
and this study benefitted from the use of a measure that distinguished 
different types of fatigue (e.g., sleep fatigue). Isolating which areas children 
are experiencing difficulties may help tailor interventions and understand 
underlying mechanisms. However, it should be recognised that the definition 
and measurement of fatigue is still under development (McCabe, 2009)  
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By using the Behaviour Rating Inventory of Executive Function (Gioia et al., 
2000a), it was possible to gain information from those that may know the 
children best. Neuropsychological testing would have increased the demand 
for child participants and may have resulted in a smaller sample size. 
However, the BRIEF should not be considered a replacement for cognitive 
tests as it is subject to report bias and measures different aspects of 
executive function (Anderson et al., 2002).  
 
The main limitation of this study was that it was a cross-sectional correlational 
study. When considering associations between variables it was not possible 
to infer direction of influence. Longitudinal studies, including intervention 
studies, would be better suited to examine the impact of length of diagnosis 
and how changes in one variable impacts on the other variables.   
 
The total sample for this study was 37 families and therefore only had the 
power to detect moderate or large effect sizes. A larger sample would have 
allowed for more complex statistical procedures, including analysis of multiple 
variables concurrently, for instance through a multiple regression sequence. 
This may have made it possible to look at mediation and moderation effects 
of different variables and larger samples would reduce effects of multi-
collinearity due to association between variables, increasingly the possibility 
to analyse the individual contribution of each variable. However, it is likely that 
variables such as fatigue, mood and executive function would always be 
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subject to these effects given their high degree of conceptual overlap and 
influence.  
 
The visual analogue appraisal scale used in this study was a novel measure. 
This was constructed based on similar scales but intended to be shorter to 
give a snapshot of appraisal mechanisms that might be operating for this 
population. Authors have suggested that a single item or limited item scale 
may be just as valid as longer measures tapping similar constructs (Bowling, 
2005). Tests conducted on this measure showed good reliability for the parent 
scale and for the child scale, if removing one item. However, further analysis 
into the validity and reliability of this measure was not carried out and 
therefore results should be viewed with caution.  
 
From ad hoc discussion with one family completing the VAS measure with an 
interpreter, the parent commented that the question asking people to rate 
‘coping’ on a scale was not a question you would ask within their culture or 
religion. The reason for this is that coping is assumed and considered more of 
an all-or-nothing construct. The parent and child still answered and 
understood the item but this indicates that further cross-cultural validation of 
this measure may be warranted.  
 
Emotional symptoms were established from a five items, which incorporated a 
range of emotions. The Strengths and Difficulties Questionnaire (Goodman, 
1997) was chosen for its brevity and, in parallel with other measures, gave a 
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snapshot of several variables at once. However, it sacrificed depth of 
knowledge and discrimination of emotional problems experienced. It was not 
possible to establish whether children were worried, depressed, experiencing 
other feelings, or a combination. Understanding the nature of the emotional 
symptoms would help tailor intervention but also help to better understand the 
different relationships between variables. For instance, it might be expected 
that anxiety might have a greater association with quality of life as measured 
by the KIT, as several items in the KIT measure ask about the extent that 
children are worried about aspects of their condition.  
 
This study examined the association between outcome variables. This may 
illustrate the genuine relationship between these constructs. However, there 
was some overlap in measures. For instance, items on the cognitive fatigue 
measure (e.g., ‘it is hard to keep my attention on things’) would have 
overlapped with items from the BRIEF. Similarly, the KIT measure asked 
about problems with emotions. There are no subscales identified for the KIT 
measure, and its general factor structure is unclear.   This study did not use a 
more standardised and generic measure of quality of life, such as the 
Pediatric Quality of Life InventoryTM, PedsQLTM (Varni, Seid & Kurtin, 2001), 
which also meant that comparisons could not be made with other paediatric 
populations in this domain.  
 
Children were excluded if they had a co-morbid condition that was poorly 
controlled and was assessed as having the potential to significantly contribute 
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to symptoms. Eleven children in this study were allowed to participate with 
other conditions, made on clinical judgement in individual cases. Other 
conditions included, among others, diabetes, asthma, and undefined skin and 
gastrointestinal problems. Some children had multiple co-morbid conditions. 
In adults with ITP, where it was also decided not to exclude on the basis of 
co-morbid conditions, Newton et al. (2011) found that presence of co-morbid 
health conditions was a significant predictor of fatigue. It should be noted that, 
in that study, depression was also a co-morbid condition so it is not clear 
whether presence of physical, but not mental health, conditions would have 
had the same effects. The sample in the current study represents a realistic 
sample of children with ITP presenting to specialist national haematology 
service. Such co-morbidities perhaps provide support that there is some 
underlying systemic pathology in ITP (Frith et al., 2011). The sample was not 
large enough to test for differences between groups, therefore it was not clear 
the extent the results may have been affected by these conditions, compared 
with a sample of children with ITP and no other conditions.  
 
Side effects of medications were reported from clinician and clinical notes. 
This relies on children and parents knowing about the side effects of the 
medications and reporting them through clinic appointments. It is possible that 
some of the observed effects of adjustment difficulties in this study may have 
been related to treatment effects.  
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This study aimed to capture the experience of patients as young as 5 years 
old through self report. For this the PedsQLTM-Multidimensional Scale for 
Fatigue (Varni et al., 2002) was used as it has been developed and used for 
this age group. However, some of the younger children completing the 
measure (interviewed by researcher) seemed to struggle with the items. In 
particular, children struggled to answer the items that referred to ‘trouble 
starting things’ and ‘trouble finishing things’. For this the researcher gave 
some prompts to aid completion. Although this may have affected responses, 
the researcher seeing families remained constant and therefore variations in 
verbal administration instructions remained limited. More generally, the 
questions often required children to simultaneously hold in mind the last 
couple of weeks, evaluate how frequently an internal state (feeling tired) had 
occurred, and rate how much of a problem it was for them, in each question. 
Often the questions would need to be broken down and these aspects asked 
separately. Whilst it is still important that children be included in research from 
a young age, the method from which their experience is elicited may need 
further development.  
 
Parents and children were encouraged to not discuss their responses with 
each other whilst completing the questionnaires. When completing measures 
in clinic, children were not separated from their parents. This was decided as 
it may have increased anxiety for children, particularly young children, in a 
setting where this may have already been raised. Families also had the option 
to complete the questionnaires at home. Both scenarios may have meant that 
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parents and children were influenced in their responses by the presence of 
the other.  
 
On the whole, families were approached to take part in the study whilst 
attending routine clinic appointments and a large proportion of families 
completed measures on site. It is possible that anxiety was raised for children 
and parents or that they were distracted by the thoughts about the 
appointment, both of which may have affected completion of the measures. In 
particular, if anxious, and some children were noticeably anxious about the 
blood tests that were due, this may have produced a negativity bias in 
reporting. For instance, questions that asked about worry about ITP 
symptoms may have received higher scores at this time.  
 
As families were given the option to take the questionnaires away from clinic 
and return them by post, it is impossible to establish the exact amount of time 
passed between clinic appointment (and therefore most recent blood test) 
and questionnaire responses. Therefore measures of platelet count and 
questionnaire variables may relate to slightly different time points. 
 
Access to interpreters meant that data from families who did not have a good 
comprehension of English could still be captured. However, due to time 
limitations available as families presented to clinic, completion of the full 
questionnaire packs was not possible. This included exclusion of the BRIEF 
measure which was the longest measure, with 86 items. Although, this 
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affected only three participants, this is an unfortunate methodological issue 
that meant that for these families this was not captured. There were some 
comments about particular items of the measures by those who spoke good 
English (meeting inclusion criteria) but to whom English was their second 
language. This included query over the terms ‘cranky’ and ‘good attention 
span’. Providing synonyms of ‘irritable’ and ‘how long they can concentrate’ 
resolved these issues, although this deviated from the phrasing of the 
measure on these two occasions.  
 
ITP is a changeable condition; platelet count often fluctuates within weeks or 
months. It is possible that psychological symptoms similarly vary across time. 
The questionnaires used asked parents and children to comment about 
different time periods- from one week (KIT measure) to six months (BRIEF). 
Firstly, this may have caused confusion for respondents or they may have 
neglected these different instructions.  Furthermore, measures using a longer 
time frame may not have been sensitive enough to capture changes that 
might relate to fluctuating platelet count for instance. As Flores et al. 
commented (2014), children and parents may have been considering 
bleeding events further back in time than asked to comment on, or conversely 
focusing on the positive current situation but ignoring times of worse 
symptoms covered by the measures. Also, this study did not examine the 
effect of length of condition on child adjustment, and all results should be 
considered with this in mind. It is both useful to capture a long term 
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psychological profile of children with ITP, as well as recording of smaller 
changes over a short period using appropriately sensitive measures.    
 
Clinicians, who provided severity ratings were not blind to the study 
objectives. This may have affected subjective ratings. However, the bleeding 
scale used (Provan et al., 2010) provided clear descriptors that should have 
guided clinicians to make objective ratings for this domain. Being aware of 
study objectives should not have had an impact on the scores that were 
provided from the clinical records.  
 
Despite limitations, this study provides useful information about the 
psychological profile of children with ITP. Whilst some aspects of the 
condition may be similar to other conditions, some characteristics of the 
condition and its treatment, such as particular uncertainties around the illness, 
its visibility and its potential to restrict everyday life, may have a differential 
impact on children’s adjustment.  As the clinical understanding of ITP is still 
developing it is unclear whether biological or psychosocial processes can 
explain findings related to fatigue, executive functioning and emotional 
difficulties.   
 
4.10 Future research  
This study has begun to address gaps in the literature for the psychological 
profile for children with ITP and highlighted associations between different 
domains of adjustment. Although this research has highlighted potential 
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differences in psychological adjustment compared with the normal population 
it is unclear to what extent these issues are different from other chronic 
conditions. There is limited research on executive functioning and fatigue in 
different paediatric conditions. Future research should continue to use 
standardised measures to allow for comparisons across conditions.   
 
If, through future research, there was further evidence to support executive 
functioning difficulties in children with ITP, studies could also examine the 
potential for biological cause to this. It is possible that undetected blood flow 
changes in the brain are having an impact. Alternatively, the disruption of 
platelets as carriers for various biological factors may have effects in the brain 
that are not, as yet, understood. For adults with ITP, it has been suggested 
that other bodily systems may be disrupted, which could have wide-ranging 
effects including cognitive deficits (Frith et al., 2011). Whilst the presentation 
of ITP in children is quite different to adults (Schulze, & Gaedicke, 2011), this 
hypothesis may remain true.  
 
Given the discrepancies on some of the reports between parents and 
children, it is important that future studies take into account both self and 
informant reports of functioning. It is likely that there is no single objective 
‘truth’ about symptoms but that both accounts provide useful information in to 
psychological characteristics.  
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Further research may want to explore the variables investigated in this study 
alongside other factors in the risk and resistance model (Wallander & Varni, 
1992). Factors such as psychological well-being of parents, family 
background, psychological stress and functional ability may be areas for 
exploration, as well as the variables that may affect appraisal processes.  
 
As this study found significant issues in emotional functioning for some 
children, this warrants further study. Studies may wish to use more detailed 
measures of emotional functioning that could differentiate anxiety and 
depression.  A challenge for any study looking at the variables investigated 
here would be in differentiating the effects of each variable. This could be 
achieved in using different measures that have greater separation of items. 
Studies could use interventions to address particular symptoms (e.g., sleep 
hygiene, cognitive strategies, pharmacological or psychological treatment of 
mood difficulties) and observe the effect on other symptoms.  
 
It is unclear whether appraisals examined in this study were a product of 
short-term evaluations or longer-term appraisal style. Longitudinal research 
may be able to provide information on this. For instance, whether appraisals 
vary related to symptoms and severity or whether some other factor alters 
appraisals. Related to this, it would be interesting to know whether appraisals 
changed over the course of the illness, including as the condition persisted for 
long enough to be categorised as a chronic condition. This may help to 
explain differences in quality of life ratings between those with persistent and 
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chronic ITP found in previous studies (Klaassen et al., 2013; Mokhtar, Farid, 
Shaker, & Farrag, 2014). 
 
4.11 Conclusions 
This study addressed gaps in the literature in relation to the psychological 
profile of child patients with ITP, specifically to establish that difficulties in 
fatigue, emotional-behavioural functioning, and executive functioning were 
elevated for some children in this group. Adjustment variables were 
significantly related to each other. This should be understood as both 
methodological and conceptual overlap. That is, emotional symptoms, fatigue 
and executive functioning present simultaneously and in relation to each other 
but also measures may include items that address more than one symptom. It 
remains a challenge for any research examining these variables to separate 
their unique and combined contributions. Disease characteristics were not 
generally associated with these adjustment outcomes. Several variables were 
related to quality of life, findings which have theoretical and clinical 
implications. Appraisal, as explored with a bespoke measure, was related to 
adjustment and quality of life. Understanding and integrating factors that 
contribute to good adjustment outcome in paediatric settings is a difficult task. 
This study furthers knowledge in the area of ITP but also the field of quality of 
life and adjustment in paediatric conditions more broadly.   
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Appendix 1:Strengths and Difficulties Questionnaire, Self-report (11 years +)
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Appendix 2 Strengths and Difficulties Questionnaire, Parent report version
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Appendix 3PedsQL
 TM
 Multdimensional Fatigue Scale, Parent report example 
 
PedsQL 
TM
 Multidimensional Fatigue Scale. Standard Version - English 
(UK) 
PARENT REPORT for  TEENAGERS (ages 13-18) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
DIRECTIONS 
Below is a list of things that might be a problem for your child. Please tell us 
how much of a problem each one has been for your child during the past ONE 
month by circling: 
0 if it is never a problem 
1 if it is almost never a problem 
2 if it is sometimes a problem 
3 if it is often a problem 
4 if it is almost always a problem 
There are no right or wrong answers. If you do not understand a question, please ask 
for help. 
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DIRECTIONS 
Below is a list of things that might be a problem for you. Please 
tell us how much of a problem each one has been for you during 
the past ONE month by circling: 
0 if it is never a problem 
1 if it is almost never a problem 
2 if it is sometimes a problem 
3 if it is often a problem 
4 if it is almost always a problem 
 
There are no right or wrong answers. If you do not understand a question, 
please ask for help. 
Appendix 4 PedsQL
 TM
 Multdimensional Fatigue Scale, self-report example  
PedsQL TM Mulitidimensional Fatigue Scale 
Standard Version - English (UK).  
TEEN REPORT (ages 13-18) 
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Appendix 5 PedsQL
 TM
 Multdimensional Fatigue Scale, young child report  
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Appendix 5 PedsQL
 TM
 Multidimensional Fatigue Scale, young child report  
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Appendix 5 PedsQL
 TM
 Multdimensional Fatigue Scale, young child report  
How much of a problem is this for you? 
 
 
 
 
Not at all Sometimes A lot 
   
 
 
 
 
 
 
PedsQL (5-7) Fatigue Not to be reproduced without permission Copyright © 1998 JWVarni, Ph.D. 
05/01  All rights reserved 
PedsQL 
TM 
Multidimensional Fatigue Scale – Young child (5-7) - United Kingdom/English - 10 Mar 08 - Mapi Research Institute. 
ID4453 / PedsQL-3.0-Fatigue-YC-eng-GB.doc 
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Appendix 6  Behaviour Rating Inventory of Executive Function (BRIEF)  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not included due to copyright restrictions 
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Appendix 7 . Kid’s ITP Tools (KIT) – self report 
 
 
 
 
 
 
 
 
 
 
 
 
 
Not included due to copyright restrictions 
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Appendix 8  Kid s ITP tool Parent proxy report 
 
 
 
 
 
 
 
 
 
 
 
Not included due to copyright restrictions 
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Appendix 9 Visual Analogue Appraisal Scale for parents  
 
How severe would you rate your child’s illness? 
|   |   |   |   |   | 
0  1   2  3  4  5 
Not at all severe         Very 
severe 
How much does your child’s ITP affect their life?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Has no effect        Affects it a lot  
How much does your child’s ITP affect your life?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Has no effect        Affects it a lot 
How able do you feel to cope with your child’s ITP?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Not able to cope at all    Completely able to cope 
How able do you feel your child is to cope with their ITP?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Not able to cope at all    Completely able to cope 
 
What part of your child’s ITP bothers you the most? 
……………………………………………………………………… 
Visual Analogue Scale- Parent/Carer, version 1 01 July 2014 
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Appendix 10 Visual Analogue Appraisal Scale for children aged 7-16 
How bad/severe is your illness? 
 
|   |   |   |   |   | 
0  1   2  3   4  5 
Not at all severe        Very severe 
 
 
How much does ITP affect your life?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Has no effect        Affects it a 
lot  
 
 
How able do you feel to cope with your ITP?  
|   |   |   |   |   | 
0  1   2  3   4  5 
Not very able to cope    Completely able to 
cope 
 
What part of your ITP bothers you the most? 
………………………………………………………………. 
 
Visual Analogue Scale- Child version 7-16 years 01 July 2014 
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Visual Analogue Scale- Child version 5-6 year version 01 July 2014 
 
Appendix 11 Visual Analogue Appraisal Scale for children aged 5-6 
 
 
How bad is your illness?  
 
 
 
 
|   |   |   |   |   | 
0  1   2  3   4  5 
Not at all bad        Very bad 
  
 
 
 
What part of your illness worries/bothers you the most?  
 
……………………………………………………………. 
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Appendix 12 - Clinical Information sheet 
Clinical Information- ITP Project 
Name: 
 
Gender:       M   F   
 
Date of birth:           
 
Ethnicity:            
 
Date of diagnosis:          
 
Nature of ITP:    
Persistent (>3 months)   Chronic (>12 months)  
Platelet Count:            
 
Bleeding Severity (ICIS scale):        
  
Clinician subjective rating of severity (please circle):   
|   |   |   |   |   | 
0  1   2  3  4  5 
Not at all severe        Very severe 
 
Has severity of ITP changed over the last two months?     Y/  N  
If so, in what way?         
            
Current Treatment(s):         
Observed/reported side effects (current treatment):  
            
 
Length of current treatment:      
  
Previous Treatment(s):       
       
       
Other conditions/diagnoses:        
Other condition well managed or not active ?    
Previous ICH bleed?    Y/  N  
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Appendix 13 Recruitment poster 
 
 
We are doing some research at [removed] 
Hospital in to Immune Thrombocytopenia (ITP) 
in children  
 
The main areas we are looking at are fatigue, 
concentration and behaviour and how these affect 
well-being.  
Parents and children would be asked to fill in 
some questionnaires about these areas. 
 
 
 
 
 
 
 
 Are you a young person with ITP? 
 Do you have a child with ITP? 
 
 
Child ITP study 
 
If you are interested in taking part in this research 
or would like more information, please speak with 
your clinician or contact [removed], Trainee 
Clinical Psychologist/Chief Investigator on 
[removed] 
 
Recruitment poster, version 1   01/07/2014 
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Appendix 14 Parent information sheet 
 
Participant Information sheet 
Project: The thoughts, feelings and behaviours of children with 
Immune Thrombocytopenia (ITP) 
We would like to invite you and your child to take part in our research study. Before 
you decide we would like you to understand why the research is being done and 
what it would involve. One of our team will go through the information sheet with 
you and answer any questions you have. We‘d suggest this should take about 10 
minutes. 
 Part 1 tells you the purpose of this study and what will happen to you if you 
take part.  
 Part 2 gives you more detailed information about the conduct of the study.  
Ask us if there is anything that is not clear. 
 
Part 1 
Why is the study being done?  
We believe it will aid research in the important area of ITP in children. We hope the 
findings will help us to better understand the factors that influence well-being for 
children with ITP. This will enable us to provide better care and support for families 
with children with ITP.  
 
Why are we being invited to take part in the research? 
You and your child are being asked to take part as your child has ITP. We are 
hoping about 50-75 families in total will participate, recruited from NHS hospitals. 
 
Do I have to take part? 
It is up to you to decide to join the study. You or your child are free to withdraw at 
any time, without giving a reason. This would not affect the standard of care your 
child receives. You can choose to participate if your child does not participate. 
Similarly, your child can complete the questions if you do not wish to participate.  
 
What will happen if we take part? 
Children who take part in this study will be asked to complete some questions 
about their condition and how it affects them. The amount of questions will depend 
on the age of the child, taking up to maximum of 20 minutes. These will be about 
how they feel and behave, their fatigue/tiredness and some questions about what 
it’s like to have ITP.  
 
As parents/carers you will also be asked to fill in some questionnaires about your 
child. You will be asked about your child’s feelings and behaviours, their 
fatigue/tiredness and what it’s like for them to have ITP. You will also be asked 
about their thinking skills. This should take up to a maximum of 30 minutes.  
 
You can complete these at the same time as your routine clinic appointment and 
hand them straight back to us. Alternatively, we can give you an envelope to post 
them back to us. Some details from your child’s clinical notes will be provided by 
your clinician. These will be length of time since of diagnosis, bleeding severity, 
platelet count, the type and amount of treatment received and any reaction to it. No 
additional clinical tests will need to be completed. We will follow ethical and legal 
practice and all information about you will be handled in confidence. The details of 
this are included in Part 2. 
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Appendix 14 Parent information sheet 
 
 
Are there any disadvantages of taking part? 
We do not anticipate any distress to arise during the completion of these 
questionnaires. However, if you or your child experience any distress you are 
advised to speak to the main researcher (removed) in the first instance. You or 
your child can stop completing the questionnaires at any time. You could also be 
referred to the Psychology department if necessary. The study may not have direct 
benefit to you, but the information we get will help improve the treatment and 
support for other children with ITP.  
 
Part 2 
Will my information stay confidential? 
Storage of all material will adhere to the Caldicott Principles, and in line with the 
Data Protection Act (1998). The means the data will be kept only as long as is 
needed for the purposes of research and its audit, typically a maximum of 5 years 
following publication. All information which is collected about you during the course 
of the research will be kept strictly confidential, and any information about you 
which leaves the hospital/surgery will have your name and address removed so 
that you cannot be identified. Only members of research team will be allowed to 
see the raw data of the study. The only time information would be shared outside of 
this would be if you or your child told us something that suggested someone was at 
risk of serious harm. If this happened, we may need to involve other professionals. 
We would try to discuss this with you before doing so.  
 
What will happens to the results? 
The results of the study may be published. Any results published would not contain 
your name or any information that identifies you or your child.  
 
Once the research is completed, we will produce a summary of the results for 
participants. Please let us know now if you would like a copy of this. Alternatively, 
you will be able to ask your clinician for this. 
 
Who has reviewed the research? 
This study has been reviewed and approved by an independent group of people, 
called a Research Ethics Committee, and by the Psychology Department internal 
ethical procedure at Royal Holloway, University of London. [removed] have also 
given permission for this study to be carried out. The members of the research 
team have been checked and cleared by the Disclosure and Barring Service 
(previously the Criminal Records Bureau). 
 
What happens next? 
If you are happy to take part in the research, please complete the consent form 
overleaf to indicate whether you agree to take part and whether you agree for your 
child to take part in this study. Please retain this sheet for your future information. 
 
Thank you for taking the time to read this information. 
 
 
[removed]  
Trainee Clinical Psychologist/ Chief Researcher  
[removed] 
[removed] 
Principal Researcher 
[removed]   . 
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Appendix 14 Parent information sheet 
 
For more information and support around ITP, you can contact the ITP Support 
Association: www.itpsupport.org.uk, Tel:  0844 7770 559 
 
If you would like to discuss with someone whether or not you should 
participate in research generally please contact the Patient Advice and 
Liaison Service (PALS) on [removed]. 
If you have any comments or concerns during the study you may 
discuss these with the researcher who will do their best to answer your 
questions. If you wish to go further and complain about any aspect of the 
way you have been approached or treated during the study, you can do 
this through the NHS Complaints Procedure. Details for this are available 
through your clinic.   
 
 
Your signed consent form will be stored separately from the responses 
you provide 
NB: You may retain this information sheet for reference and contact us 
with any queries 
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Appendix 15 Child Information sheet (11-16 years) 
What is it like to have ITP? 
Hello. We are asking if you would join a research project about ITP. 
Before you decide if you want to join in, it‘s important to understand why 
the research is being done and what it will involve for you. So please read 
this leaflet carefully. Talk to your family, doctor or nurse if you want to 
and ask me any questions. 
I am interested in finding out about what it’s 
like to have ITP, and how this affects how you 
feel. This is important to help us understand 
the experience of young people with ITP better and offer 
support at the right times. 
 
You have been invited because you have 
ITP and between the age of 5 and 16 
years old. 
 
 
No. If you don’t want to take part that’s 
OK. Your decision to take part or not will 
not affect any of the treatment you receive. If you do take part, it’s also 
OK for you to decide to stop doing the research at any time or choose not 
to answer a particular question. You don’t even have to say why. As you are 
under 16 years old your parent or carer will also agree for you to join in 
this project.  
 
 
If you decide to take part, you will be given some questionnaires to 
complete. These will be about how tired you are, how you feel and what it’s 
like to have ITP. These should take up to 20 minutes. You can fill them in 
whilst you are at the clinic or you can take them home and we can give you 
an envelope to send them back to us. Your parent or carer will also be 
asked to complete some questions but they can say no to this if they wish. 
 
 
 
 
What is the research about? 
Why have I been invited?  
What would I have to do? 
 
Do I have to take part? 
 
Information sheet for young people 11-16, version 2.  01/07/2014  
 
 
 
192 
Appendix 15 Child Information sheet (11-16 years) 
 
 
We will keep your information private and confidential- the answers you 
give will be collected and only looked at by members of the research team. 
The questionnaires will not have your name on and so your answers will not 
be able to be linked to you.  
The only time I would have to tell someone about what had been written or 
said was if you (or your parent/carer) said something that makes us 
worried that someone may be at risk. Then we may need to talk to someone 
else about this. We would let you know if we needed to do this.    
 
 
 
I can't promise that this study will help you directly but the results will 
help to improve future care for young people living with ITP. You can ask to 
be sent a summary report of what we found out from the study once the 
study has been completed. 
 
 
 
The study has been checked by a group of people called a Research Ethics 
Committee who have decided that this research is fair and safe. 
We don’t expect you will have any problems taking part- we just want to 
hear about your views! But if you are not happy about anything you can tell 
me or talk to your doctor or nurse, or your parents/carers. You have the 
choice to leave the study at any time if you want to. 
Thank you for taking time to read about this study. 
 
 
 
If you decide that you want to take part, that’s great. As you are under 16 
years old, you and your parent/guardian will need to sign the consent 
forms attached.   
If you have any further questions or comments, you can ask your 
parents or doctor for my contact details 
For more information and support around ITP, see the  
ITP Support Association: www.itpsupport.org.uk  
Could anything bad happen if I take part?  
What will happen to the information I give you? 
 
So if I do want to take part, what should I do now? 
 
What are the possible benefits of taking part? 
Information sheet for young people 11-16, version 2.  01/07/2014  
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Project for children with problems with their blood  
- what is it like? 
 
My name is Sarah. I am learning to be a 
psychologist.  
 
We want to find out more about what it’s like to have 
problems with your blood.  
 
You are being asked to take part in this project 
because you have something wrong with your 
blood.  
 
You can choose if you want to take part are not.  
 
 
If you want to take part, you 
will either be asked some 
questions or you will write 
things down about what it’s 
like to have problems with your blood.  
 
 
This will take up to 20 minutes.  
 
 
 
 
What you write or say will be kept private. 
 
 
 
 
 
 
Me? 
Hello!!! 
Child information sheet 5-10 years, Version 2 01/07/2014 
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You can stop at any time. You can choose not to 
answer a question 
 
 
 
If you are upset about anything in the 
questions, you can tell your parent, doctor 
or me.  
 
 
 
We cannot promise the study will help you but the 
information we get might help other children who have 
problems with their blood.  
 
 
 
 
 
 
 
 
 
 
 
Do you have any questions? 
 
 
 
 
 
 
 
 Child information sheet 5-10 years, Version 2                            01/07/2014 
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ASSENT FORM FOR CHILDREN AND YOUNG PEOPLE  
 
Project title : Problems with your blood- what is it like? / How do young 
people feel who have ITP? 
 
 
Young person/child (or if unable, parent on their behalf) to circle all they 
agree with:  
 
Have you read about this project or has  
somebody else explained this project to you?  Yes/No 
Do you understand what this project is about?   Yes/No  
Have you asked all the questions you want?    Yes/No  
Have you had your questions       
answered in a way you understand?      Yes/No 
Do you understand it’s OK to stop taking part at any time? Yes/No  
Do you understand your information      
 will be kept safe and private?     Yes/No  
Are you happy to take part?      Yes/No  
 
If any answers are “no” or you don’t want to take part, don’t sign your name!  
 
If you do want to take part, you can write your name below  
 
Your name        Date  
 
The person who explained this project to you needs to sign too:  
 
Print Name     Sign    Date  
 
Thank you for your help. 
Child YP Assent Form, Version:  2                                                  01/07/2014 
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Appendix 18 Consent form for 16 year olds 
Consent form for young people, 16 years and over 
Title of project: The thoughts, feelings and behaviours of children with 
ITP 
Name of Chief investigator:  [removed] 
 
1. I confirm that I have read and understood the young person 
information sheet dated 01/07/2014 (version 2) for the above study 
and have had the opportunity to ask questions. 
 
2. I confirm that I have had sufficient time to consider whether or not I 
want to participate in the study  
 
 
3. I understand that my participation is voluntary and that I am free to 
withdraw at any time, without giving any reason, without my 
medical care or legal rights being affected 
 
 
4. 
 
I understand that selected/relevant details from my medical notes 
will be used in this study.  
 
5. I understand that my data will be anonymised and identifying 
information removed. 
 
 
6. I understand that relevant data collected during the study may be 
looked at by individuals from regulatory authorities or from the NHS 
Trust, where it is relevant to my taking part in this research.  I give 
permission for these individuals to have access to this data. 
 
 
       
NB. Your signed consent form will be stored separately from the 
responses you provide 
 
  
  
I have read the above and I agree to participate in the above study.  
(please tick above boxes and sign below) 
 
 
______________  ____________  ______________ 
Name (please print)  Date    Signature 
 
_________________    ___________ _______________ 
Researcher (to be contacted  Date   Signature 
if there are any problems)  
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Consent form for parents and guardians 
Title of project: The thoughts, feelings and behaviours of children with 
ITP 
Name of Chief investigator:  [removed] 
       
1. I confirm that I have read and understood the information sheet dated 
01/07/2014 (version 2) for the above study and have had the opportunity 
to ask questions. 
 
2. I confirm that I have had sufficient time to consider whether or not I want 
my child to be included in the study  
 
3. I confirm that I have had sufficient time to consider whether or not I want 
to participate in the study  
 
4. I understand that my participation and that of my son/daughter is 
voluntary and that either of us are free to withdraw at any time, without 
giving any reason, without my child’s medical care or legal rights being 
affected 
 
5. 
 
I understand that selected/relevant details from my child’s medical notes 
will be used in this study.  
 
6. I understand that data from me and/or my child will be anonymised and 
identifying information removed. 
 
7. I understand that relevant data collected during the study may be looked 
at by individuals from regulatory authorities or from the NHS Trust, where 
it is relevant to my taking part in this research.  I give permission for these 
individuals to have access to this data. 
 
  
I have read the above and agree for my child to take part in the above 
study.  
(please tick the above boxes and sign)  
 
 
NB. Your signed consent form will be stored separately from the 
responses you provide 
 
__________   __________   ______________ 
Name of parent    Date    Signature 
 
     
Name of child (please print)  
  
I have read the above and I agree to participate in the above study. 
(please tick and sign) 
 
 
_________   ____________  ______________ 
Name of parent    Date    Signature 
 
__________     ___________ ____________ 
Researcher (to be contacted  Date   Signature 
if there are any problems)  
 198 
Appendix 20 Demographics form  
 
Please do not put your name or your child’s name anywhere in this booklet 
 
Please complete the following:  
 
 
Your age           
 
Your gender     M   F     
    
 
Age of your child          
   
 
Gender of your child    M   F     
        
 
Your relationship to child (e.g. parent):      
 
 
 
 
Your ethnicity (please tick):         
  
         
 White British 
 Other White background  
 Black British 
 Black African 
 Black Caribbean  
 Other Black background  
 Indian 
 Pakistani 
 Bangladeshi 
 Other Asian background  
 Black Caribbean and 
White 
 Black African and White  
 Asian and White 
 Other Dual Heritage 
 Chinese  
 Traveller 
 Other Ethnic Group 
 Prefer not to say 
 
 
 
Ethnicity of child (please specify if different)       
   
or   same ethnicity  
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Appendix 21 Royal Holloway Research sub-committee approval  
Memorandum 
 
To:   [removed] 
From:  [removed] (on behalf of the Research Sub- 
Committee and Course Executive) 
Date:  13th February 2014 
Copy To: [removed] 
Re:   Main Research Project Proposal 
 
 
The Research Sub-Committee has considered your Main Research Project Proposal 
response and has decided to give you Approval.  Your research costs have also 
been approved.  Please note that if these costs change and you do not re-submit an 
amended form for approval prior to incurring any additional costs, these additional 
costs will not be reimbursed. 
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Appendix 22 Clinical site Research committee approval  
 
[removed] 
Psychosocial Services 
[removed] 13
th 
June 2014 
 
Dear [removed] 
Title: The Cognitive, 
Behavioural and 
Psychological Profile 
of Children with ITP 
and Factors 
Influencing their 
Wellbeing 
R&D Ref: 14HT02 
Funding: Clinical Own Account Decision: Scientific Approval 
 
I am writing to inform you that the [Research Committee] reviewed your 
application and has no objections to the conduct of this project at   [removed]. 
 
The Committee has some comments on the Project, which are in preparation and I 
shall send these on to you shortly. In the meantime, I thought it best to inform you 
of the Committee’s approval and wish you well with your Ethics application. 
 
You will shortly receive a checklist of documents that are required for R&D 
approval. Once all the documents have been received you will receive and R&D 
approval email and you can commence your project. 
 
 
Kind Regards 
 
 
Professor [removed] 
Chair 
[Research Committee] 
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[removed] 
Psychosocial Services 
[removed]        10th  July 2014  
 
Dear [removed] 
Title: The Cognitive, Behavioural and Psychological Profile of Children with 
Immune Thrombocytopenia Purpura (ITP) and Factors Influencing their Wellbeing 
 
R&D Ref: 14HT02 
Funding: Clinical Own Account  
Decision: Scientific Approval 
 
Further to the Scientific Approval letter that I sent you on 13th June 2014 I am 
writing to let you have the comments from the [Research committee] member who 
presented your project to the committee on 10th June 2014. I hope that you find 
these comments helpful. 
 
[removed] 18month DClin study from Royal Holloway. 
 
Study looking at the effects of ITP on children and their families. 
Treatment just based on platelet count, bleeding. Aim to look at 
common secondary characteristics (fatigue, difficulties with 
concentration impacting academic performance and behaviour 
problems, impact on well- being and qofL) and determine if these 
should be factored into treatment decision. Also known that cognitive 
appraisal impact on adjustment to a chronic illness and this will be 
evaluated. 
Cohort/Inclusions/exclusions Main group is parents and children” if 
there is enough of them”. 49-66 participants required based on power 
calculation from 75 patients seen /year. If not sufficient are 
considering approaching other centres. We advised to do this early 
on given issues of time taken with local research approvals 
particularly as they need high opt in in order to have sufficient power. 
 
Also plan to exclude those who do not have a “reasonable” command 
of English or if they have a disability. Would be appropriate to define 
“reasonable” (eg not requiring an interpreter) and  “disability” needs to 
be expanded eg.  learning, communication, hearing impairment etc 
 
Methods: How are the features of fatigue and concentration likely to 
affect questionnaire completion? 
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Committee  
Some concerns as to how data collection will be completed by the 
parent and child in the same session if the parent needs to help the 
child. Needs to be clear which are completed on own, with researcher, 
with parent. Says researcher will conduct the questionnaires with the 
young children. How will they engage young children to do this? Will 
parent need to help the younger children? Will the researcher need to 
ensure only so many patients per clinic? Would be helpful to pilot the 
process not just for time taken but logistics. 
 
Advised optimum would be for all the parent questionnaires to be 
completed in the same context ie clinic. Is it possible that forms 
completed at home could be completed differently, and there is the risk 
that these would not be completed and returned. 
 
Analysis It is unclear how the VAS cognitive appraisal measures will 
be analysed; they are not part of either hypothesis. ITP categories 
needed as there are degrees of severity. Suggested mild, moderate, 
severe and should be based on previous literature. 
 
Other comments: Needs a GAANT chart and signatures on the form, 
suggest the cohort is called Children and Young People, the written 
information sheets will need to be adjusted for the age group. The PPI is 
good. 
 
 
I just need to remind you that neither this letter nor the 
previous one constitute R&D approval and that you may 
not start your project till the Research Governance 
department has issued you with a formal R&D approval 
letter. 
 
Kind Regards 
 
 
Professor [removed] 
Chair 
[Research Committee] 
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Appendix 24 NHS NRES Ethics Favourable opinion with conditions
  
 
National Research Ethics Service 
 
[removed] 
 
 
04 August 2014 [removed] 
Royal Holloway, University of London Egham 
Surrey TW20 0EX 
 
Dear [removed] 
 
Study title: The cognitive, behavioural and 
psychological profile of children with ITP 
and factors influencing their well- being. REC reference: 14/NW/1172 
IRAS project ID: 146242 
 
The Proportionate Review Sub-committee of the NRES Committee North West - 
Greater Manchester West reviewed the above application on 01 August 2014. 
 
We plan to publish your research summary wording for the above study on the 
NRES website, together with your contact details, unless you expressly withhold 
permission to do so. 
Publication will be no earlier than three months from the date of this 
favourable opinion letter. Should you wish to provide a substitute contact point, 
require further information, or wish to make a request to postpone publication, 
please contact the REC Manager [removed], [removed]  
 
Ethical opinion 
 
On behalf of the Committee, the sub-committee gave a favourable ethical opinion of 
the above research on the basis described in the application form, protocol and 
supporting documentation, subject to the conditions specified below. 
 
Conditions of the favourable opinion 
 
The favourable opinion is subject to the following conditions being met prior to the 
start of the study. 
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1. The Committee would like the Participant Information for 5-10 
year olds revised to change the clock to say 20 minutes not 25 
minutes. 
2. The Committee would the footer on the parents information sheet 
amended, this is not a consent form. 
3. The Committee would like the fields over all the dates on 
documents removed and replaced with a fixed date which should 
match the dates submitted on the checklist. 
 
You should notify the REC in writing once all 
conditions have been met (except for site approvals 
from host organisations) and provide copies of any 
revised documentation with updated version 
numbers. The REC will acknowledge receipt and 
provide a final list of the approved documentation 
for the study, which can be made available to host 
organisations to facilitate their permission for the 
study. Failure to provide the final versions to the 
REC may cause delay in obtaining permissions. 
 
Management permission or approval must be obtained from each host 
organisation prior to the start of the study at the site concerned. 
 
Management permission (“R&D approval”) should be sought from all 
NHS organisations involved in the study in accordance with NHS 
research governance arrangements. 
 
Guidance on applying for NHS permission for research is available in the 
Integrated Research Application System or at http://www.rdforum.nhs.uk. 
 
Where a NHS organisation’s role in the study is limited to identifying and 
referring potential participants to research sites (“participant identification 
centre”), guidance should be sought from the R&D office on the information 
it requires to give permission for this activity. 
 
For non-NHS sites, site management permission should be obtained in 
accordance with the procedures of the relevant host organisation. 
 
Sponsors are not required to notify the Committee of approvals from host 
organisations. 
 
Registration of Clinical Trials 
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All clinical trials (defined as the first four categories on the IRAS filter page) 
must be registered on a publically accessible database within 6 weeks of 
recruitment of the first participant (for medical device studies, within the timeline 
determined by the current registration and publication trees). 
 
There is no requirement to separately notify the REC but you should do so at the 
earliest opportunity e.g. when submitting an amendment. We will audit the 
registration details as part of the annual progress reporting process. 
 
To ensure transparency in research, we strongly recommend that all research is 
registered but for non-clinical trials this is not currently mandatory. 
 
If a sponsor wishes to contest the need for registration they should contact 
Catherine Blewett (catherineblewett@nhs.net), the HRA does not, however, 
expect exceptions to be made. 
Guidance on where to register is provided within IRAS. 
It is the responsibility of the sponsor to ensure that 
all the conditions are complied with before the start 
of the study or its initiation at a particular site (as 
applicable). 
 
Ethical review of research sites 
 
The favourable opinion applies to all NHS sites taking part in the study, subject 
to management permission being obtained from the NHS/HSC R&D office prior 
to the start of the study (see “Conditions of the favourable opinion”). 
Summary of discussion at the meeting 
 
Informed consent process and the adequacy and completeness of 
participant information 
 
The Committee requested the changes as noted in the favourable opinion with 
conditions. 
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Approved documents 
 
The documents reviewed and approved were: 
 
Document Version Date 
Copies of advertisement materials for research participants 
[Recruitment poster] 
1 01 July 2014 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Indemnity Cover letter] 
1 02 September 
2013 
IRAS Checklist XML [Checklist_17072014]  17 July 2014 
Letter from statistician [Statistician comments] 1 16 April 2014 
Non-validated questionnaire [Parent Visual Analogue Scale] 1 01 July 2014 
Non-validated questionnaire [7-16 Visual Analogue Scale] 1 01 July 2014 
Non-validated questionnaire [5-7 Visual Analogue Scale] 1 01 July 2014 
Participant consent form [Child assent form] 1 01 July 2014 
Participant consent form [Parent consent form] 1 01 July 2014 
Participant consent form [16 YP] 1 23 July 2014 
Participant information sheet (PIS) [Young child Info sheet] 1 01 July 2014 
Participant information sheet (PIS) [Parent info sheet] 1 01 July 2014 
Participant information sheet (PIS) [11-16 child Info sheet] 1 01 July 2014 
REC Application Form [REC_Form_17072014]  17 July 2014 
Research protocol or project proposal [Major Project Proposal] 3 01 July 2014 
Summary CV for Chief Investigator (CI) […………..CV] 1 01 April 2014 
Summary CV for student [Student CV] 1 01 April 2014 
Summary CV for supervisor (student research) [Academic 
Supervisor CV] 
1 20 February 
2014 
Validated questionnaire [KIT measure child] UK v.1 01 August 
2007 
Validated questionnaire [Kit measure Parent] Uk v. 1 01 August 
2007 
Validated questionnaire [PedsQL Fatigue]   
Validated questionnaire [SDQ child]   
Validated questionnaire [SDQ parent]   
 
Membership of the Proportionate Review Sub-
Committee 
The members of the Sub-Committee who took part in the review are listed on the 
attached sheet. 
Statement of compliance 
The Committee is constituted in accordance with the Governance Arrangements 
for Research Ethics Committees and complies fully with the Standard Operating 
Procedures for Research Ethics Committees in the UK. 
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After ethical review 
 
Reporting requirements 
 
The attached document “After ethical review – guidance for researchers” gives 
detailed guidance on reporting requirements for studies with a favourable opinion, 
including: 
 
 Notifying substantial amendments 
 Adding new sites and investigators 
 Notification of serious breaches of the protocol 
 Progress and safety reports 
 Notifying the end of the study 
 
The HRA website also provides guidance on these topics, which is updated in the 
light of changes in reporting requirements or procedures. 
 
Feedback 
 
You are invited to give your view of the service that you have received from the 
National Research Ethics Service and the application procedure. If you wish to 
make your views known please use the feedback form available on the HRA 
website http://www.hra.nhs.uk/about-the- hra/governance/quality-assurance/ 
 
We are pleased to welcome researchers and R & D staff at our NRES committee 
members’ training days – see details at http://www.hra.nhs.uk/hra-training/ 
 
With the Committee’s best wishes for the success of this project. 
 
14/NW/1172 Please quote this number on all 
correspondence 
 
Yours sincerely 
 
[removed] 
 
(Research committee) Chair 
 
Email: [removed]  
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Enclosures: List of names and professions of members who 
took part in the review 
 
“After ethical review – guidance for researchers”  
Copy to: [removed] 
[removed] 
 
Attendance at PRS Sub-Committee of 
the REC meeting on 01 August 2014 
 
Committee Members: 
 
Name Profession Present Notes 
[removed] Consultant in 
Communicable Diseases 
Yes  
[removed] Lay Member Yes  
[removed] Consultant in Public 
Health Medicine 
Yes  
 
Also in attendance: 
 
Name Position (or reason for attending) 
[removed] REC Manager 
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National Research Ethics Service 
 
 
[removed] 
11 August 2014 [removed] 
Royal Holloway, University of London Egham 
Surrey TW20 0EX 
 
 
Dear [removed] 
Study title: The cognitive, behavioural and psychological 
profile of children with ITP and factors influencing 
their well- being. REC reference: 14/NW/1172 
IRAS project ID: 146242 
 
Thank you for your email of 5 August 2014. I can confirm the REC has received the 
documents listed below and that these comply with the approval conditions detailed in our 
letter dated 04 August 2014 
Documents received 
The documents received were as follows: 
 
Document Version Date 
Participant consent form [16 Years and Above] 2 23 July 2014 
Participant consent form [Assent Form] 2 01 July 2014 
Participant consent form [Parent] 2 01 July 2014 
Participant information sheet (PIS) [Parents] 2 01 July 2014 
Participant information sheet (PIS) [5-10 Years Olds] 2 01 July 2014 
Participant information sheet (PIS) [11-16 Year Olds] 2 01 July 2014 
 
Approved documents 
The final list of approved documentation for the study is therefore as follows: 
 
Document Version Date 
Copies of advertisement materials for research participants 
[Recruitment poster] 
1 01 July 2014 
Evidence of Sponsor insurance or indemnity (non NHS Sponsors 
only) [Indemnity Cover letter] 
1 02 September 2013 
IRAS Checklist XML [Checklist_17072014]  17 July 2014 
Letter from statistician [Statistician comments] 1 16 April 2014 
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Non-validated questionnaire [7-16 Visual Analogue Scale] 1 01 July 2014 
Non-validated questionnaire [Parent Visual Analogue Scale] 1 01 July 2014 
Non-validated questionnaire [5-7 Visual Analogue Scale] 1 01 July 2014 
Participant consent form [16 Years and Above] 2 23 July 2014 
Participant consent form [Parent] 2 01 July 2014 
Participant consent form [Assent Form] 2 01 July 2014 
Participant information sheet (PIS) [Parents] 2 01 July 2014 
Participant information sheet (PIS) [11-16 Year Olds] 2 01 July 2014 
Participant information sheet (PIS) [5-10 Years Olds] 2 01 July 2014 
REC Application Form [REC_Form_17072014]  17 July 2014 
Research protocol or project proposal [Major Project Proposal] 3 01 July 2014 
Summary CV for Chief Investigator (CI) […………. CV] 1 01 April 2014 
Summary CV for student [Student CV] 1 01 April 2014 
Summary CV for supervisor (student research) [Academic 
Supervisor CV] 
1 20 February 2014 
Validated questionnaire [PedsQL Fatigue]   
Validated questionnaire [Kit measure Parent] Uk Version 1 01 August 2007 
Validated questionnaire [SDQ child]   
Validated questionnaire [KIT measure child] UK Version 1 01 August 2007 
Validated questionnaire [SDQ parent]   
 
You should ensure that the sponsor has a copy of the final documentation for the study. It 
is the sponsor's responsibility to ensure that the documentation is made available to R&D 
offices at all participating sites. 
 
14/NW/1172 Please quote this number on all 
correspondence  
Yours sincerely 
[removed] 
REC Manager 
 
E-mail: [removed]  
 
 
Copy to: [removed] 
[removed] 
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          [removed]
 
15/08/2014 
[removed] 
 
Dear [removed], 
Project Title :  The cognitive, behavioural and 
psychological profile  of children with ITP and 
factors  influencing their well-being 
Protocol version  3 
Protocol date  1st July 2014 
REC Reference 14/NW/1172 
R&D Reference 14HT02 
Sponsor  Royal Holloway University of London [removed] 
 
Notification of [removed] Hospital NHS Permission. 
 
The research approval process for the above named study has 
been completed successfully. I am pleased to issue approval, on 
behalf of [removed] for the above study to proceed. 
All research carried out within this Trust must be in accordance 
with the principles set out in the Research Governance Framework 
for Health and Social Care (April 2005, 2nd edition, Department of 
Health (DH)). 
This approval is issued on the basis of the project documentation 
submitted to date. The approval may be invalidated in the event that 
the terms and conditions of any research contract or agreement 
change significantly and while the new contract/agreement  is 
negotiated. 
The conditions for host site approval are as follows: 
• [removed] must have appropriate contractual arrangements in place with 
[removed] to participate in this research study. 
• The Principal Investigator {PI) must ensure compliance with protocol and 
advise the Joint R&D Office of any change(s) to the protocol. Failure of 
notification may affect host approval status. 
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• Under the terms of the Research Governance Framework (RGF), the PI 
is obliged to report any Serious Adverse Events (SAEs) to the Sponsor 
and the Joint R&D Office in line with the study protocol and Sponsor 
requirements. Adverse Incidents (AEs) must also  be  reported  in 
accordance with the Trust Adverse Incident Reporting Policy & Procedures. 
• The PI must ensure appropriate procedures are in place to action  
 urgent safety measures. 
 
 
 
 
• The PI is responsible for the set up and maintenance of the Investigator 
Site File (ISF) generated to store all documentation relating to this 
project. 
• The PI must ensure that all named staff are compliant wit the Data 
Protection Act (DPA) 1998, Human Tissue Act  (HTA) Mental 
Capacity Act (MCA) 2005 and all other applicable statutory guidance 
and legislation. 
• The PI must allow monitoring and auditing by the Sponsor and the Joint 
R&D Office. 
• The PI must report any cases of suspected research misconduct and 
fraud to the Joint R&D Office. 
• The PI must provide an annual report to the Joint R&D Office for all 
research involving NHS patients, staff and/or resources. The PI must 
notify the Joint R&D Office of any presentations of such research at 
scientific or professional meetings, or on the event of papers being 
published and any direct or indirect impacts on patient care. 
 
 
Failure to comply with the above conditions and regulations will 
result in the suspension of the research project. 
 
Please contact the Joint R&D Office if you require any further 
guidance or information on any matter mentioned above. We 
wish you every success in your research. 
 
Yours sincerely, 
 
 
 
[removed] 
Research M anagement 
and Governance Officer 
Joint Research and 
Development Office 
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ITP project- results summary 
 
We investigated several areas of well-being for children with ITP that have 
not been looked at in previous research.  
 
We asked children and their parents about behaviour, tiredness, thinking 
skills, and what it’s like to have ITP.  
 
We found that:  
 Children with ITP have more problems with tiredness than children 
without ITP  
 Some children with ITP have problems with feeling sad or worried at 
times, and this was more so than another group of children without 
ITP  
 Some children with ITP have difficulties with ‘thinking skills’ which we 
call ‘executive functioning’. These are a particular set of thinking skills 
concerned with planning and organising, initiation, and self-
regulation.  
 Generally, platelet count was not associated with tiredness, thinking 
skills or well-being 
 Parents rated their child’s ITP as worse than children themselves did, 
and also worse than clinicians felt it was. 
 Children with lower bleeding severities felt more able to cope with the 
condition 
 Findings indicated that subjective ratings of the illness may have 
been more important that objective ratings (ie. platelet count)  
 
Parents and children commented that what they were particularly worried 
about were visual signs of ITP, the uncertainty about the condition, the 
restriction on activities and blood tests.  
 
The above results are based on the average scores for all children that took 
part. However, on all measures, the majority of children were not having 
significant difficulties and were managing well despite their ITP.  
 
These are similar findings as found in other children with physical health 
conditions. More research is needed to help us know what results in better 
outcome for some children and not others. These findings help us develop 
care and support for children and families with experience of ITP.  
 
If you have any further questions or comments, please contact [removed], 
Chief Researcher, by email, [removed]  
 
 
 
